<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archivearticle1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">3864932</article-id><article-id pub-id-type="pmid">24358164</article-id><article-id pub-id-type="publisher-id">PONE-D-13-38887</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0082285</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="0" pm="."><plain>Identification of Crucial Amino Acids in Mouse Aldehyde Oxidase 3 That Determine Substrate Specificity </plain></SENT>
</text></SecTag></article-title><alt-title alt-title-type="running-head">Site Directed Mutagenesis of mAOX3</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Mahro</surname><given-names>Martin</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Brás</surname><given-names>Natércia F.</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Cerqueira</surname><given-names>Nuno M. F. S. A.</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Teutloff</surname><given-names>Christian</given-names></name><xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Coelho</surname><given-names>Catarina</given-names></name><xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Romão</surname><given-names>Maria João</given-names></name><xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Leimkühler</surname><given-names>Silke</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref></contrib></contrib-group><aff id="aff1">
<label>1</label>
<addr-line>Department of Molecular Enzymology, Institute of Biochemistry and Biology, University of Potsdam, Potsdam, Germany</addr-line>
</aff><aff id="aff2">
<label>2</label>
<addr-line>REQUIMTE, Departamento de Quimica, Faculdade de Ciencias, Universidade do Porto, Porto, Portugal</addr-line>
</aff><aff id="aff3">
<label>3</label>
<addr-line>Institute for Experimentalphysics, Free University of Berlin, Berlin, Germany</addr-line>
</aff><aff id="aff4">
<label>4</label>
<addr-line>REQUIMTE, Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, Caparica, Portugal</addr-line>
</aff><contrib-group><contrib contrib-type="editor"><name><surname>Pastore</surname><given-names>Annalisa</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">
<addr-line>National Institute for Medical Research, Medical Research Council, London, United Kingdom</addr-line>
</aff><author-notes><corresp id="cor1">* E-mail: <email>sleim@uni-potsdam.de</email></corresp><fn fn-type="COI-statement"><p><text><SENT sid="1" pm="."><plain>Competing Interests: The authors have declared that no competing interests exist. </plain></SENT>
</text></p></fn><fn fn-type="con"><p><text><SENT sid="2" pm="."><plain>Performed the experiments: MM NFB CC. </plain></SENT>
<SENT sid="3" pm="."><plain>Analyzed the data: MM NFB NMFSAC CT CC MJR SL. </plain></SENT>
<SENT sid="4" pm="."><plain>Contributed reagents/materials/analysis tools: MM NFB NMFSAC CT CC MJR SL. </plain></SENT>
<SENT sid="5" pm="."><plain>Wrote the paper: MM NMFSAC CC MJR SL. </plain></SENT>
</text></p></fn></author-notes><pub-date pub-type="collection"><year>2013</year></pub-date><pub-date pub-type="epub"><day>16</day><month>12</month><year>2013</year></pub-date><volume>8</volume><issue>12</issue><elocation-id>e82285</elocation-id><history><date date-type="received"><day>20</day><month>9</month><year>2013</year></date><date date-type="accepted"><day>1</day><month>11</month><year>2013</year></date></history><permissions><copyright-statement>© 2013 Mahro et al</copyright-statement><copyright-year>2013</copyright-year><copyright-holder>Mahro et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p></license></permissions><abstract><p><SecTag type="ABS"><text><SENT sid="6" pm="."><plain>In order to elucidate factors that determine substrate specificity and activity of mammalian molybdo-flavoproteins we performed site directed mutagenesis of mouse aldehyde oxidase 3 (mAOX3). </plain></SENT>
<SENT sid="7" pm="."><plain>The sequence alignment of different aldehyde oxidase (AOX) isoforms identified variations in the active site of mAOX3 in comparison to other AOX proteins and xanthine oxidoreductases (XOR). </plain></SENT>
<SENT sid="8" pm="."><plain>Based on the structural alignment of mAOX3 and bovine XOR, differences in amino acid residues involved in substrate binding in XORs in comparison to AOXs were identified. </plain></SENT>
<SENT sid="9" pm="."><plain>We exchanged several residues in the active site to the ones found in other AOX homologues in mouse or to residues present in bovine XOR in order to examine their influence on substrate selectivity and catalytic activity. </plain></SENT>
<SENT sid="10" pm="."><plain>Additionally we analyzed the influence of the [2Fe-2S] domains of mAOX3 on its kinetic properties and cofactor saturation. </plain></SENT>
<SENT sid="11" pm="."><plain>We applied UV-VIS and EPR monitored redox-titrations to determine the redox potentials of wild type mAOX3 and mAOX3 variants containing the iron-sulfur centers of mAOX1. </plain></SENT>
<SENT sid="12" pm="."><plain>In addition, a combination of molecular docking and molecular dynamic simulations (MD) was used to investigate factors that modulate the substrate specificity and activity of wild type and AOX variants. </plain></SENT>
<SENT sid="13" pm="."><plain>The successful conversion of an AOX enzyme to an XOR enzyme was achieved exchanging eight residues in the active site of mAOX3. </plain></SENT>
<SENT sid="14" pm="."><plain>It was observed that the absence of the K889H exchange substantially decreased the activity of the enzyme towards all substrates analyzed, revealing that this residue has an important role in catalysis. </plain></SENT>
</text></SecTag></p></abstract><funding-group><funding-statement>This work was supported by the Cluster of Excellence “Unifying Concepts in Catalysis” (to C.T. and S.L.) coordinated by the Technische Universität Berlin and funded by the Deutsche Forschungsgemeinschaft. The exchange of researchers among laboratories involved in the work was funded by the DAAD-GRICES program (to MJ Romão and S Leimkühler). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="12"/></counts></article-meta></front><body><SecTag type="INTRO"><sec id="s1"><title><text><SENT sid="15" pm="."><plain>Introduction </plain></SENT>
</text></title><p><text><SENT sid="16" pm="."><plain>Aldehyde oxidases (AOX, EC 1.2.3.1) are complex molybdo-flavoenzymes (MFEs) containing two distinct [2Fe-2S] centers, FAD and the molybdenum cofactor (Moco) as catalytically acting units. </plain></SENT>
<SENT sid="17" pm="."><plain>The enzymes are homodimers in eukaryotes and belong to the family of xanthine oxidases (XO) of molybdoenzymes. </plain></SENT>
<SENT sid="18" pm="."><plain>Despite their high sequence identity of about 50%, AOXs and xanthine oxidoreductases (XOR) use different sets of substrates. </plain></SENT>
<SENT sid="19" pm="."><plain>Both enzymes display a broad substrate specificity acting on activated carbon atoms in -C = N- and -C(-H) = O bonds [1], [2]. </plain></SENT>
<SENT sid="20" pm="."><plain>While XORs prefer low substituted purines as substrates, AOXs prefer higher substituted aromatic compounds. </plain></SENT>
<SENT sid="21" pm="."><plain>MFEs in general are characterized by a homodimeric butterfly-shaped structure of about 300 kDa in size. </plain></SENT>
<SENT sid="22" pm="."><plain>Three subdomains of each subunit containing three different cofactors characterize the structure of mammalian MFEs, a 20 kDa N-terminal [2Fe-2S] domain, a 40 kDa central FAD-containing domain and an 85 kDa C-terminal molybdenum cofactor (Moco) domain [3], [4]. </plain></SENT>
<SENT sid="23" pm="."><plain>The Moco of eukaryotic AOX and XOR is further modified by an equatorial sulfur ligand coordinating the molybdenum atom, which is essential for their catalytic function [5], [6]. </plain></SENT>
<SENT sid="24" pm="."><plain>The oxidation of substrates starts with a base-catalyzed nucleophilic addition of Mo-OH to the reducing substrate and concerted hydride transfer from the reducing substrate to the Mo = S moiety. </plain></SENT>
<SENT sid="25" pm="."><plain>The molybdenum is reduced from +VI to +IV in this reaction. </plain></SENT>
<SENT sid="26" pm="."><plain>The covalent intermediate is hydrolyzed by water releasing the oxidized product [7]. </plain></SENT>
<SENT sid="27" pm="."><plain>The electrons are transferred via the two [2Fe-2S] centers (FeSI nearest to the Moco and FeSII nearest to the FAD [8]) to the FAD cofactor. </plain></SENT>
<SENT sid="28" pm="."><plain>In AOX enzymes molecular oxygen is used as terminal electron acceptor, producing mainly H2O2. </plain></SENT>
<SENT sid="29" pm="."><plain>In XORs, the oxidase form (XO) uses O2 as electron acceptor, while the dehydrogenase form (XDH) prefers NAD+ as electron acceptor [9]. </plain></SENT>
<SENT sid="30" pm="."><plain>The inability of the oxidase form to reduce NAD+ has been assigned to structural changes upon oxidation or proteolytic cleavage that block the NAD+ binding site by sterical hindrance [10]. </plain></SENT>
<SENT sid="31" pm="."><plain>Alongside, the oxidase form shows a ∼170 mV more positive reduction potential of the FADH°/FADH2 couple in comparison to the dehydrogenase form, which preferentially yields the two electron reduced form of FAD being able to react with molecular oxygen [11]. </plain></SENT>
<SENT sid="32" pm="."><plain>So far, rabbit liver AOX is the only eukaryotic AOX for which redox potentials were determined [12]. </plain></SENT>
<SENT sid="33" pm="."><plain>The order of redox potentials of the FAD/FADH° couple and the FADH°/FADH2 couple of rabbit liver AOX was shown to be comparable to the one identified in XOs [9]. </plain></SENT>
</text></p><p><text><SENT sid="34" pm="."><plain>While XORs have a defined role in the catabolism of purines, the physiological role of AOXs is not known and only at the beginning to be understood [3]. </plain></SENT>
<SENT sid="35" pm="."><plain>Recent results imply a role in lipid-homeostasis and UV-light response [13]–[15] as well as pheromone reception [16]. </plain></SENT>
<SENT sid="36" pm="."><plain>While XORs are encoded by a single species-specific gene, for AOX enzymes different isoforms were identified in different species. </plain></SENT>
<SENT sid="37" pm="."><plain>Rodents and marsupials contain the largest number of Aox functional genes: Aox1, Aox3, Aox4, and Aox3l1 [17], [18]. </plain></SENT>
<SENT sid="38" pm="."><plain>These genes arose from a series of gene duplication events from a common ancestor and are clustered on a short region of mouse chromosome 1 and rat chromosome 9. </plain></SENT>
<SENT sid="39" pm="."><plain>All of the products of the mammalian Aox genes have high amino acid sequence similarity and are expressed in a tissue-specific manner in different organisms [3], [19]. </plain></SENT>
<SENT sid="40" pm="."><plain>It is believed that the various AOX isoforms recognize distinct substrates and carry out different physiological tasks. </plain></SENT>
<SENT sid="41" pm="."><plain>The tissue distribution of mouse AOX3 (mAOX3) is superimposable to that of mAOX1, and the two enzymes are synthesized predominantly in liver, lung, and testis [20]. </plain></SENT>
<SENT sid="42" pm="."><plain>The expression of mAOX4 is limited to the Harderian gland, esophagus and skin, whereas mAOX3L1 expression is restricted to the nasal mucosa [21]. </plain></SENT>
<SENT sid="43" pm="."><plain>mAOX4 was shown to metabolize retinaldehyde into retinoic acid and plays a role in skin homeostasis [13]. </plain></SENT>
<SENT sid="44" pm="."><plain>Due to low-abundance and overlapping tissue-distribution purification of one AOX-isoform is difficult without any cross-contaminations of other AOX-isoforms. </plain></SENT>
<SENT sid="45" pm="."><plain>Therefore, little is known about substrate specificities and kinetic properties of the different AOX isoforms. </plain></SENT>
<SENT sid="46" pm="."><plain>Independently from the physiological role of AOXs, inter-species and inter-individual differences in AOX promoted drug metabolism has evolved to a challenging issue in drug development [22]. </plain></SENT>
<SENT sid="47" pm="."><plain>Understanding the mechanisms determining the different substrate specificities and the factors determining the reactivity of AOX is one of the main goals in this field. </plain></SENT>
<SENT sid="48" pm="."><plain>Recent recombinant expression systems in hand enabled to meet the increasing interest in understanding the molecular bases of AOXs substrate specificity. </plain></SENT>
</text></p><p><text><SENT sid="49" pm="."><plain>In this study we use the existing recombinant expression system for mAOX3 in Escherichia coli to study the basis of catalytic activity and substrate selectivity of mAOX3 in comparison to other AOX homologues from mouse and bovine XOR (bXOR). </plain></SENT>
<SENT sid="50" pm="."><plain>We exchanged amino acids in the first and second coordination sphere of the mAOX3 active site to amino acids found in XOR and other AOX isoforms. </plain></SENT>
<SENT sid="51" pm="."><plain>The variant mAOX3-F776K/A807E/D878L/L881S/Y885R/P1015T/Y1019L showed drastically decreased activity towards all substrates tested. </plain></SENT>
<SENT sid="52" pm="."><plain>Additional introduction of K889H substitution rescued AOX activity and resulted in a XOR-like activity with hypoxanthine as substrate. </plain></SENT>
<SENT sid="53" pm="."><plain>Additionally, we introduced the iron-sulfur center domains of mAOX1 in mAOX3. </plain></SENT>
<SENT sid="54" pm="."><plain>Changes in activity as well as iron-sulfur center I (FeSI) formal potentials were observed. </plain></SENT>
</text></p></sec></SecTag><SecTag type="RESULTS,DISCUSS"><sec id="s2"><title><text><SENT sid="55" pm="."><plain>Results and Discussion </plain></SENT>
</text></title><sec id="s2a"><title><text><SENT sid="56" pm="."><plain>Site-directed mutagenesis of mAOX3 </plain></SENT>
</text></title><p><text><SENT sid="57" pm="."><plain>In order to determine the role of different amino acids in the active sites of AOXs, the variants mAOX3-F1014I, mAOX3-F1014V, mAOX3-P1015A and mAOX3-P1015G were generated. </plain></SENT>
<SENT sid="58" pm="."><plain>Additionally, we performed “whole domain” exchanges to study differences in the intramolecular electron transfer. </plain></SENT>
<SENT sid="59" pm="."><plain>We exchanged the [2Fe-2S]-containing domains of mAOX3 to the ones present on mAOX1 to study their influence on electron transfer and catalytic activity of mAOX3. </plain></SENT>
<SENT sid="60" pm="."><plain>The variant mAOX3-FeSII-mAOX1 exhibits the amino acids M1 – P76 from mAOX1 instead of M1 – P80 of mAOX3. </plain></SENT>
<SENT sid="61" pm="."><plain>In mAOX3-FeSI-mAOX1, A87 – Q214 of mAOX3 is exchanged by T83 – Q213 of mAOX1 and mAOX3-FeSII-FeSI-mAOX1 possesses M1 – Q213 from mAOX1 replacing M1 – Q214 from mAOX3. </plain></SENT>
<SENT sid="62" pm="."><plain>In order to study amino acids, which determine the substrate specificity of XOR enzymes in comparison to AOX enzymes, we performed numerous exchanges of amino acids in the first and second coordination sphere of the active site of mAOX1 to the ones present in bXOR. </plain></SENT>
<SENT sid="63" pm="."><plain>The variant named mAOX3-“active site1” contains the seven amino acid exchanges F776K/A807E/D878L/L881S/Y885R/P1015T/Y1019L in mAOX3, which represent highly conserved amino acids in XOR enzymes (Fig. 1). </plain></SENT>
<SENT sid="64" pm="."><plain>The mAOX3-“active site1”-K889H variant contains in addition the K889H exchange, since the lysine was shown to be involved in substrate binding in AOX enzymes [23]. </plain></SENT>
<SENT sid="65" pm="."><plain>All variants named “gating loop” contain the amino acid exchanges K889H/S1011G/V1012I/G1013S/K1016V/Y1020N, which are in the vicinity of the active site. </plain></SENT>
<SENT sid="66" pm="."><plain>These amino acids are part of a hydrogen-bond network in the second coordination sphere of XORs, which is mainly build by R880 (Y885 in mAOX3), G1006-S1008 (S1011-G1013 in mAOX3) and N1015 (Y1020 in mAOX3). </plain></SENT>
<SENT sid="67" pm="."><plain>All 11 mAOX3 variants were expressed and purified from 28 – 112 liter cultures as described previously for mAOX3 wild type [24]. Figure 2 shows wild type mAOX3 and the purified variants separated on an 8% native polyacrylamide gel. </plain></SENT>
<SENT sid="68" pm="."><plain>All variants were purified as dimers with a comparable yield of 0.5 – 1.2 mg/L of culture and a purity of approx. </plain></SENT>
<SENT sid="69" pm="."><plain>95%. </plain></SENT>
<SENT sid="70" pm="."><plain>As shown in Table 1, all variants showed a comparable molybdopterin (MPT) saturation of 62±24% – 139±37% relative to mAOX3 wild type. </plain></SENT>
<SENT sid="71" pm="."><plain>The iron content was found to be similar with a saturation ranging from 49±15% to 75±24%. </plain></SENT>
<SENT sid="72" pm="."><plain>The ratio of absorbance at 444 nm and 550 nm was around 3.2 for all variants, showing an equal ratio of FAD to the 2x[2Fe-2S] clusters. </plain></SENT>
<SENT sid="73" pm="."><plain>Molybdenum saturation ranged from 45±8% to 101±16%. </plain></SENT>
<SENT sid="74" pm="."><plain>The molybdenum to MPT ratio in all variants was found to be comparable to the mAOX3 wild type, showing an unaltered amount of the demolybdo form of MPT present in the purified proteins. </plain></SENT>
<SENT sid="75" pm="."><plain>The ratio of absorbance at 280 nm and 444 nm in the UV-Vis spectra of all variants were identical in the range of 4.9 – 5.7, showing an almost 100% saturation of the variants with FAD [24]. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="pone-0082285-g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0082285.g001</object-id><label>Figure 1</label><caption><title><text><SENT sid="76" pm="."><plain>Amino acid sequence alignment of selected parts of mAOX homologues and bovine XOR. </plain></SENT>
</text></title><p><text><SENT sid="77" pm="."><plain>Shown is an amino acid sequence alignment of the region of amino acids 770-1030 of mAOX3 with the other AOX-isoform from mouse and bovine XOR (bXOR). </plain></SENT>
<SENT sid="78" pm="."><plain>Identical amino acid residues are shaded in black, homologous amino acid residues are shaded in grey. </plain></SENT>
<SENT sid="79" pm="."><plain>For clarity, residues exchanged in mAOX3-“active site1”-K889H variant are boxed in black. </plain></SENT>
<SENT sid="80" pm="."><plain>A grey box marks the position of mAOX3-F1014 and mAOX3-P1015 variants. </plain></SENT>
<SENT sid="81" pm="."><plain>The six residues exchanged in the mAOX3-“gating loop” variants are underlined. </plain></SENT>
<SENT sid="82" pm="."><plain>The alignment was created with CLC Sequence viewer Ver. </plain></SENT>
<SENT sid="83" pm="."><plain>6.8.2. </plain></SENT>
</text></p></caption><graphic xlink:href="pone.0082285.g001"/></fig></SecTag><SecTag type="FIG"><fig id="pone-0082285-g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0082285.g002</object-id><label>Figure 2</label><caption><title><text><SENT sid="84" pm="."><plain>8% native-PAGE of mAOX3 wild type and variants. </plain></SENT>
</text></title><p><text><SENT sid="85" pm="."><plain>Lanes 1–12 contain 3–5 µg of purified protein, stained with Coomassie-brilliant blue. </plain></SENT>
<SENT sid="86" pm="."><plain>1, mAOX3 WT; 2, mAOX3-“active site1”; 3, mAOX3-“active site1”-K889H; 4, mAOX3-“active site1 + gating loop”; 5, mAOX3-“gating loop”; 6, mAOX3-FeSI-mAOX1; 7, mAOX3-FeSII-mAOX1; 8, mAOX3-FeSII-FeSI-mAOX1; 9, mAOX3-P1015A; 10, mAOX3-P1015G; 11, mAOX3-F1013I; 12, mAOX3-F1014V. </plain></SENT>
</text></p></caption><graphic xlink:href="pone.0082285.g002"/></fig></SecTag><SecTag type="TABLE"><table-wrap id="pone-0082285-t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0082285.t001</object-id><label>Table 1</label><caption><title><text><SENT sid="87" pm="."><plain>Determination of the cofactor composition of the mAOX3 variants. </plain></SENT>
</text></title></caption><alternatives><graphic id="pone-0082285-t001-1" xlink:href="pone.0082285.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="88" pm="."><plain>% Mo content1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="89" pm="."><plain>% Fe content1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="90" pm="."><plain>% MPT content2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="91" pm="."><plain>A280/A444 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="92" pm="."><plain>A444/A550 </plain></SENT>
</text></td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="93" pm="."><plain>mAOX3-WT </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="94" pm="."><plain>62±13 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="95" pm="."><plain>57±7 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="96" pm="."><plain>100±10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="97" pm="."><plain>5.2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="98" pm="."><plain>3.3 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="99" pm="."><plain>mAOX3-F1014I </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="100" pm="."><plain>70±9 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="101" pm="."><plain>65±17 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="102" pm="."><plain>62±24 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="103" pm="."><plain>5.2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="104" pm="."><plain>3.1 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="105" pm="."><plain>mAOX3-F1014L </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="106" pm="."><plain>45±8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="107" pm="."><plain>49±15 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="108" pm="."><plain>1006 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="109" pm="."><plain>5.2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="110" pm="."><plain>3.2 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="111" pm="."><plain>mAOX3-P1015A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="112" pm="."><plain>55±9 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="113" pm="."><plain>75±24 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="114" pm="."><plain>105±2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="115" pm="."><plain>5.7 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="116" pm="."><plain>3.1 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="117" pm="."><plain>mAOX3-P1015G </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="118" pm="."><plain>60±4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="119" pm="."><plain>67±1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="120" pm="."><plain>116±2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="121" pm="."><plain>5.4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="122" pm="."><plain>3.2 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="123" pm="."><plain>mAOX3-FeSI-mAOX1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="124" pm="."><plain>79±4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="125" pm="."><plain>64±1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="126" pm="."><plain>106±10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="127" pm="."><plain>5.6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="128" pm="."><plain>3.4 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="129" pm="."><plain>mAOX3-FeSII-mAOX1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="130" pm="."><plain>96±12 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="131" pm="."><plain>73±18 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="132" pm="."><plain>139±37 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="133" pm="."><plain>5.6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="134" pm="."><plain>3.1 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="135" pm="."><plain>mAOX3-FeSII-FeSI-mAOX1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="136" pm="."><plain>101±16 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="137" pm="."><plain>69±10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="138" pm="."><plain>128±14 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="139" pm="."><plain>5.7 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="140" pm="."><plain>3.3 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="141" pm="."><plain>mAOX3-“active site1” </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="142" pm="."><plain>46±1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="143" pm="."><plain>52±0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="144" pm="."><plain>96±3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="145" pm="."><plain>5.1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="146" pm="."><plain>3.5 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="147" pm="."><plain>mAOX3-“active site1”-K889H </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="148" pm="."><plain>63±3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="149" pm="."><plain>63±0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="150" pm="."><plain>87±11 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="151" pm="."><plain>4.9 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="152" pm="."><plain>3.3 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="153" pm="."><plain>mAOX3-“active site1 + gating loop” </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="154" pm="."><plain>85±6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="155" pm="."><plain>58±3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="156" pm="."><plain>73±22 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="157" pm="."><plain>5.4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="158" pm="."><plain>3.2 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="159" pm="."><plain>mAOX3-“gating loop” </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="160" pm="."><plain>60±2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="161" pm="."><plain>66±1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="162" pm="."><plain>75±2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="163" pm="."><plain>5.1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="164" pm="."><plain>3.3 </plain></SENT>
</text></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt101"><p><text><SENT sid="165" pm="."><plain>µM molybdenum/µM enzyme) and iron (µM 2 x [2Fe2S]/µM enzyme) contents were determined by ICP-OES (see Experimental procedures).1 Molybdenum ( </plain></SENT>
</text></p></fn><fn id="nt102"><p><text><SENT sid="166" pm="."><plain>%.2 Determined after conversion to the stable oxidized fluorescent product FormA. </plain></SENT>
<SENT sid="167" pm="."><plain>mAOX3-WT was set to 100 </plain></SENT>
</text></p></fn><fn id="nt103"><p><text><SENT sid="168" pm="."><plain>Relative molybdopterin (MPT) saturation, molybdenum and iron saturation and ratio of absorbance at 280 nm, 444 nm and 550 nm of mAOX3 variants in comparison to reported values for the wild type enzyme. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag></sec><sec id="s2b"><title><text><SENT sid="169" pm="."><plain>Analysis of the role of residues F1014 and P1015 in mAOX3 </plain></SENT>
</text></title><p><text><SENT sid="170" pm="."><plain>The crystal structure of mAOX3 suggested that A807, Y885, K889, F919 and F1014 are directly involved in substrate-binding in mAOX3 [23]. </plain></SENT>
<SENT sid="171" pm="."><plain>An amino acid sequence alignment of mAOX3 with mAOX1, mAOX4, mAOX3I1 and bovine XOR showed differences in conservation of residues in the active site among the enzymes (Figure 1). </plain></SENT>
<SENT sid="172" pm="."><plain>The residues A807 and Y885 present in mAOX3 are highly conserved in AOX1 enzymes and are replaced by valine and a methionine in other isoforms, respectively (Figure1). </plain></SENT>
<SENT sid="173" pm="."><plain>F919 is highly conserved between all vertebrate AOX and XOR enzymes, while F1014 is only conserved in XOR enzymes and varies among AOX homologues. </plain></SENT>
<SENT sid="174" pm="."><plain>To study the role of F1014 of mAOX3, we exchanged it to an isoleucine (present in mAOX1) and a valine (present in mAOX4) [18]. </plain></SENT>
<SENT sid="175" pm="."><plain>The adjacent amino acid P1015 is also not conserved. </plain></SENT>
<SENT sid="176" pm="."><plain>To study its role, we exchanged mAOX3-P1015 to a glycine (present in mAOX1) and to an alanine (present in mAOX3l1). </plain></SENT>
<SENT sid="177" pm="."><plain>The catalytic constants of mAOX3 wild type, mAOX3-F1014I, mAOX3-F1014V, mAOX3-P1015A and mAOX3-P1015G are shown in Table 2. </plain></SENT>
<SENT sid="178" pm="."><plain>All values were corrected for a molybdenum saturation of 100% of each variant for a better comparability. </plain></SENT>
<SENT sid="179" pm="."><plain>In comparison to mAOX3 wild type, the variant mAOX3-F1014I showed a 7.4–33 fold decreased catalytic efficiency (kcat/KM) with benzaldehyde, phthalazine and phenanthridine. </plain></SENT>
<SENT sid="180" pm="."><plain>Both, the substrate affinity and rate of conversion were affected by the F1014I exchange. </plain></SENT>
<SENT sid="181" pm="."><plain>mAOX3-F1014I was determined to be inactive with allopurinol and N1-methylnicotinamide as substrates. </plain></SENT>
<SENT sid="182" pm="."><plain>Replacement of F1014 by valine resulted in a 2.1–11 fold decrease in catalytic efficiency with all substrates. </plain></SENT>
<SENT sid="183" pm="."><plain>However, the KM values of the mAOX3-F1014V variant were higher in comparison to wild type mAOX3. </plain></SENT>
<SENT sid="184" pm="."><plain>In contrast, the kcat with benzaldehyde and phthalazine was increased, while the kcat with N1-methylnicotinamide and phenanthridine remained unchanged. </plain></SENT>
<SENT sid="185" pm="."><plain>Allopurinol was oxidized with a 4.6 - fold lower kcat by mAOX3-F1014V in comparison to mAOX3 wild type. </plain></SENT>
<SENT sid="186" pm="."><plain>The catalytic constants were also altered by variation of P1015 to alanine or glycine. </plain></SENT>
<SENT sid="187" pm="."><plain>The catalytic efficiency of mAOX3-P1015A and mAOX3-P1015G with benzaldehyde and phthalazine was comparable to mAOX3 wild type. </plain></SENT>
<SENT sid="188" pm="."><plain>N1-methylnicotinamide was converted with a higher catalytic efficiency by variants mAOX3-P1015A and mAOX3-P1015G in comparison to mAOX3 wild type. </plain></SENT>
<SENT sid="189" pm="."><plain>The catalytic efficiency (kcat/KM) with phenanthridine was higher for the variants mAOX3-P1015A and mAOX3-P1015G in comparison to wild type mAOX3. </plain></SENT>
<SENT sid="190" pm="."><plain>The increase in catalytic efficiency with allopurinol was comparable for both mAOX3-P1015 variants. </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="pone-0082285-t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0082285.t002</object-id><label>Table 2</label><caption><title><text><SENT sid="191" pm="."><plain>Steady-state kinetic parameters of mAOX3 wildtype and mAOX3 variants containing single amino acid exchanges in the active site. </plain></SENT>
</text></title></caption><alternatives><graphic id="pone-0082285-t002-2" xlink:href="pone.0082285.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="192" pm="."><plain>substrate </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="193" pm="."><plain>kinetic parameters3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="194" pm="."><plain>mAOX3-WT4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="195" pm="."><plain>mAOX3-F1014I </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="196" pm="."><plain>mAOX3-F1014V </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="197" pm="."><plain>mAOX3-P1015A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="198" pm="."><plain>mAOX3-P1015G </plain></SENT>
</text></td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="199" pm="."><plain>benzaldehyde 1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="200" pm="."><plain>kcat [min−1] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="201" pm="."><plain>68±15 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="202" pm="."><plain>19±3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="203" pm="."><plain>128±12 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="204" pm="."><plain>76±14 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="205" pm="."><plain>93±7 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="206" pm="."><plain>KM [µM] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="207" pm="."><plain>2.5±0.2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="208" pm="."><plain>22.7±2.7 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="209" pm="."><plain>21.5±3.2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="210" pm="."><plain>2.2±0.1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="211" pm="."><plain>3.3±0.2 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="212" pm="."><plain>kcat/KM [min−1 µM−1] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="213" pm="."><plain>27.0±6.4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="214" pm="."><plain>0.8±0.2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="215" pm="."><plain>5.9±1.0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="216" pm="."><plain>34.7±6.4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="217" pm="."><plain>28±2.7 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="218" pm="."><plain>phthalazine 1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="219" pm="."><plain>kcat [min−1] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="220" pm="."><plain>66±15 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="221" pm="."><plain>58±9 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="222" pm="."><plain>278±14 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="223" pm="."><plain>179±38 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="224" pm="."><plain>347±64 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="225" pm="."><plain>KM [µM] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="226" pm="."><plain>1.4±0.2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="227" pm="."><plain>9.0±0.5 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="228" pm="."><plain>12.5±0.6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="229" pm="."><plain>2.6±0.3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="230" pm="."><plain>10.3±2 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="231" pm="."><plain>kcat/KM [min−1 µM−1] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="232" pm="."><plain>47.3±12.7 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="233" pm="."><plain>6.4±1.0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="234" pm="."><plain>22.3±1.5 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="235" pm="."><plain>68.9±16.6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="236" pm="."><plain>33.7±9 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="237" pm="."><plain>phenanthridine 2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="238" pm="."><plain>kcat [min−1] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="239" pm="."><plain>85±18 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="240" pm="."><plain>11±3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="241" pm="."><plain>85±11 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="242" pm="."><plain>581±153 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="243" pm="."><plain>530±49 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="244" pm="."><plain>KM [µM] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="245" pm="."><plain>32±1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="246" pm="."><plain>73±18 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="247" pm="."><plain>385±70 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="248" pm="."><plain>99±15 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="249" pm="."><plain>47±2 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="250" pm="."><plain>kcat/KM [min−1 µM−1] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="251" pm="."><plain>2.63±0.58 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="252" pm="."><plain>0.16±0.05 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="253" pm="."><plain>0.22±0.05 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="254" pm="."><plain>5.88±1.8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="255" pm="."><plain>11.37±1.19 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="256" pm="."><plain>N1-methylnicotineamide 1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="257" pm="."><plain>kcat [min−1] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="258" pm="."><plain>24±5 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="259" pm="."><plain>n.d. </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="260" pm="."><plain>23±1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="261" pm="."><plain>65±11 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="262" pm="."><plain>115±8 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="263" pm="."><plain>KM [µM] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="264" pm="."><plain>128±5.8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="265" pm="."><plain>n.d. </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="266" pm="."><plain>482.3±28 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="267" pm="."><plain>87±3.4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="268" pm="."><plain>88.7±2.3 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="269" pm="."><plain>kcat/KM [min−1 µM−1] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="270" pm="."><plain>0.185±0.4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="271" pm="."><plain>- </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="272" pm="."><plain>0.047±0.004 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="273" pm="."><plain>0.743±0.132 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="274" pm="."><plain>1.297±1.101 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="275" pm="."><plain>allopurinol 1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="276" pm="."><plain>kcat [min−1] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="277" pm="."><plain>73±16 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="278" pm="."><plain>n.d. </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="279" pm="."><plain>16±2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="280" pm="."><plain>46±9 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="281" pm="."><plain>37±4 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="282" pm="."><plain>KM [µM] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="283" pm="."><plain>1595±73 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="284" pm="."><plain>n.d. </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="285" pm="."><plain>3860±567 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="286" pm="."><plain>527±63 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="287" pm="."><plain>426±56 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="288" pm="."><plain>kcat/KM [min−1 µM−1] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="289" pm="."><plain>0.0457±0.0103 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="290" pm="."><plain>- </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="291" pm="."><plain>0.0041±0.0008 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="292" pm="."><plain>0.0871±0.0203 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="293" pm="."><plain>0.0864±0.0145 </plain></SENT>
</text></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt104"><p><text><SENT sid="294" pm="."><plain>µM DCPIP was used as terminal electron receptor.1 100 </plain></SENT>
</text></p></fn><fn id="nt105"><p><text><SENT sid="295" pm="."><plain>2 Molecular oxygen in air saturated buffer was used as terminal electron acceptor. </plain></SENT>
</text></p></fn><fn id="nt106"><p><text><SENT sid="296" pm="."><plain>°C; kcat was corrected for molybdenum content3 Determined in 50 mM Tris (HCl) pH 8.00 at 37 </plain></SENT>
</text></p></fn><fn id="nt107"><p><text><SENT sid="297" pm="."><plain>[23] and corrected for molybdenum content.4 Values from </plain></SENT>
</text></p></fn><fn id="nt108"><p><text><SENT sid="298" pm="."><plain>n.d.: non detectable </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag><p><text><SENT sid="299" pm="."><plain>In summary, exchange of F1014 to valine or isoleucine resulted in a decrease in substrate affinity and catalytic efficiency with all substrates tested. </plain></SENT>
<SENT sid="300" pm="."><plain>Thus, valine and isoleucine might interfere with substrate binding due to steric interferences. </plain></SENT>
<SENT sid="301" pm="."><plain>The increase in KM is consistent with the higher KM values determined for mAOX1 containing an isoleucine at this position with these substrates [25]. </plain></SENT>
<SENT sid="302" pm="."><plain>In contrast, the higher rate constants with benzaldehyde and phthalazine obtained for mAOX1 were not observed with the mAOX3-F1014I variant, however, exchange of mAOX3-P1015 by alanine or glycine resulted a higher kcat with bulky and charged substrates. </plain></SENT>
<SENT sid="303" pm="."><plain>These changes might be based on two effects in the mAOX3-P1015 variants. </plain></SENT>
<SENT sid="304" pm="."><plain>The smaller side chain of alanine and glycine increases the flexibility of the peptide backbone and the ability of Y885 to flip away from the substrate, as suggested previously [23]. </plain></SENT>
<SENT sid="305" pm="."><plain>This might result in a better access of the substrate to K889, thereby resulting in tighter binding and/or better stabilization of the transition state. </plain></SENT>
<SENT sid="306" pm="."><plain>However, there is an up to 30-fold difference in the catalytic efficiency with benzaldehyde between mAOX1 (kcat/Km  = 3.34±0.56 min−1µM−1), hAOX1 (kcat/Km  = 0.91±0.17 min−1µM−1) and mAOX3 (kcat/Km  = 27.03±6.37 min−1µM−1) [23], [25], [26]. </plain></SENT>
<SENT sid="307" pm="."><plain>While the mAOX3-F1014I variant resembled the variation of catalytic efficiency between mAOX1 and mAOX3, the up to 20-fold difference in the rate constant between mAOX1, mAOX3 and hAOX1 was not observed by a single variation of F1014 or P1015. </plain></SENT>
<SENT sid="308" pm="."><plain>Thus, more factors might contribute to the difference in the catalytic constants of the AOX homologues. </plain></SENT>
</text></p></sec><sec id="s2c"><title><text><SENT sid="309" pm="."><plain>The role of FeSI and FeSII on electron transfer and activity of mAOX3 </plain></SENT>
</text></title><p><text><SENT sid="310" pm="."><plain>To analyze the effect of the two [2Fe2S] clusters for substrate conversion in AOX enzymes, we generated three variants by exchanging FeSI, FeSII and both FeSI/FeSII in mAOX3 by the domains of mAOX1. </plain></SENT>
<SENT sid="311" pm="."><plain>The kinetic parameters (Table 3) of the iron-sulfur domain variants were determined using molecular oxygen (with the substrate phenanthridine) or DCPIP as terminal electron acceptors in order to exclude mediator-based side effects. </plain></SENT>
<SENT sid="312" pm="."><plain>As shown in Table 3, the exchanges of the iron-sulfur center domains in mAOX3 to the ones present in mAOX1 did result in a decrease in catalytic activity with all substrates tested. </plain></SENT>
<SENT sid="313" pm="."><plain>A decrease of reaction rate was obtained for both electron acceptors, DCPIP (accepting electrons from Moco [27], [28]) and O2 (reacting with the FAD site). </plain></SENT>
<SENT sid="314" pm="."><plain>The effect on catalytic activity was less pronounced for the FeSI variant, while the highest decrease in the catalytic activity was observed for the variant containing both iron-sulfur domains of mAOX1. </plain></SENT>
<SENT sid="315" pm="."><plain>Additionally, we determined the reduction potentials of the cofactors present in the protein (Table 4). </plain></SENT>
<SENT sid="316" pm="."><plain>The reduction potentials for the FAD/FADH2 redox pairs were found to be similar in all variants. </plain></SENT>
<SENT sid="317" pm="."><plain>These values are close to the FAD°/FADH2 reduction potential determined for rabbit AO (−212 mV) [12]. </plain></SENT>
<SENT sid="318" pm="."><plain>No detectable amount of FAD-semiquinone was observed during the titration process. </plain></SENT>
<SENT sid="319" pm="."><plain>Exchange of the iron-sulfur domains had only minor effects on the reduction potential of FeSII. </plain></SENT>
<SENT sid="320" pm="."><plain>By exchange of FeSI or FeSI/FeSII to the ones found in mAOX1, a lower reduction potential of FeSI was observed. </plain></SENT>
<SENT sid="321" pm="."><plain>The reduction potentials of the MoIV/V and MoV/VI redox couples in mAOX3 wild type were found to be similar for all three iron-sulfur domain mAOX3-variants (Table 4). </plain></SENT>
<SENT sid="322" pm="."><plain>A linear correlation according to the Marcus theory was only observed for the reduction potential difference between the MoV/VI redox pair and FeSI, with values for the electronic coupling matrix of HAB  = 5.76×10−16±2.14×10−16 and reorganization energy of λ  = 2.57×104±6.84×103 J/mol. </plain></SENT>
<SENT sid="323" pm="."><plain>A previous report by Itoh et al. [29] examined the effect of Moco domain swop between monkey and rat AOX on the conversion of (S)-RS-8359. </plain></SENT>
<SENT sid="324" pm="."><plain>The authors observed that the substrate affinity and susceptibility to substrate inhibition of the chimeric variants was equal to the enzyme from which the Moco domain originated. </plain></SENT>
<SENT sid="325" pm="."><plain>The rate constant of the chimeric variants on the other hand was equal to the enzyme from which the iron-sulfur/FAD part originated. </plain></SENT>
<SENT sid="326" pm="."><plain>It was concluded that the rate of conversion is controlled by the iron-sulfur/FAD part, whereas the Moco domain defines substrate affinity and susceptibility to substrate inhibition. </plain></SENT>
<SENT sid="327" pm="."><plain>Our results show that substrate affinities of all iron-sulfur domain variants were unchanged. </plain></SENT>
<SENT sid="328" pm="."><plain>Exchange of the FeSII domain influenced the reduction potential of FeSI, but not the reduction potentials of Moco or FAD. </plain></SENT>
<SENT sid="329" pm="."><plain>Thus, in consistence with the results of the domain swapping of the rat enzyme, the rate of substrate conversion is not determined by the redox potential of the molybdenum atom. </plain></SENT>
<SENT sid="330" pm="."><plain>It is rather determined by structural effects induced by the domain swapping of the FeS domains influencing the electron transfer reaction by a change of the redox potential of the FeS clusters. </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="pone-0082285-t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0082285.t003</object-id><label>Table 3</label><caption><title><text><SENT sid="331" pm="."><plain>Steady-state kinetic parameters of mAOX3 wild type and mAOX3 variants containing the FeS-domains of mAOX1. </plain></SENT>
</text></title></caption><alternatives><graphic id="pone-0082285-t003-3" xlink:href="pone.0082285.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="332" pm="."><plain>substrate </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="333" pm="."><plain>kinetic parameters3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="334" pm="."><plain>mAOX3-WT4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="335" pm="."><plain>mAOX3-FeSI-mAOX1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="336" pm="."><plain>mAOX3-FeSII-mAOX1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="337" pm="."><plain>mAOX3-FeSII-FeSI-mAOX1 </plain></SENT>
</text></td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="338" pm="."><plain>benzaldehyde 1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="339" pm="."><plain>kcat [min−1] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="340" pm="."><plain>68±15 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="341" pm="."><plain>48±3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="342" pm="."><plain>38±5 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="343" pm="."><plain>23±4 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="344" pm="."><plain>KM [µM] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="345" pm="."><plain>2.5±0.2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="346" pm="."><plain>3.6±0.3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="347" pm="."><plain>1.6±0.1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="348" pm="."><plain>2.2±0.1 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="349" pm="."><plain>kcat/KM [min−1 µM−1] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="350" pm="."><plain>27±6.4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="351" pm="."><plain>13.4±1.5 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="352" pm="."><plain>23.7±1.9 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="353" pm="."><plain>10.3±1.9 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="354" pm="."><plain>phthalazine 1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="355" pm="."><plain>kcat [min−1] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="356" pm="."><plain>66±15 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="357" pm="."><plain>45±3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="358" pm="."><plain>32±5 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="359" pm="."><plain>30±5 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="360" pm="."><plain>KM [µM] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="361" pm="."><plain>1.4±0.2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="362" pm="."><plain>1.2±0.1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="363" pm="."><plain>1.4±0.2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="364" pm="."><plain>1.0±0.1 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="365" pm="."><plain>kcat/KM [min−1 µM−1] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="366" pm="."><plain>47.3±12.7 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="367" pm="."><plain>38.3±3.9 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="368" pm="."><plain>22.9±4.8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="369" pm="."><plain>29.1±5.3 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="370" pm="."><plain>phenanthridine 2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="371" pm="."><plain>kcat [min−1] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="372" pm="."><plain>85±18 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="373" pm="."><plain>43±3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="374" pm="."><plain>26±4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="375" pm="."><plain>25±4 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="376" pm="."><plain>KM [µM] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="377" pm="."><plain>32±1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="378" pm="."><plain>35±2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="379" pm="."><plain>30±5 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="380" pm="."><plain>28±2 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="381" pm="."><plain>kcat/KM [min−1 µM−1] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="382" pm="."><plain>2.63±0.58 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="383" pm="."><plain>1.23±0.1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="384" pm="."><plain>0.88±0.21 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="385" pm="."><plain>0.87±0.17 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="386" pm="."><plain>allopurinol 1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="387" pm="."><plain>kcat [min−1] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="388" pm="."><plain>73±16 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="389" pm="."><plain>25±2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="390" pm="."><plain>20±4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="391" pm="."><plain>10±2 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="392" pm="."><plain>KM [µM] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="393" pm="."><plain>1595±73 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="394" pm="."><plain>1338±43 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="395" pm="."><plain>899±145 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="396" pm="."><plain>1026±108 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="397" pm="."><plain>kcat/KM [min−1 µM−1] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="398" pm="."><plain>0.0457±0.0103 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="399" pm="."><plain>0.0185±0.0013 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="400" pm="."><plain>0.022±0.0055 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="401" pm="."><plain>0.01±0.0022 </plain></SENT>
</text></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt109"><p><text><SENT sid="402" pm="."><plain>µM DCPIP was used as terminal electron receptor.1 100 </plain></SENT>
</text></p></fn><fn id="nt110"><p><text><SENT sid="403" pm="."><plain>2 Molecular oxygen in air saturated buffer was used as terminal electron acceptor. </plain></SENT>
</text></p></fn><fn id="nt111"><p><text><SENT sid="404" pm="."><plain>°C; kcat was corrected for molybdenum content3 Determined in 50 mM Tris HCl pH 8.00 at 37 </plain></SENT>
</text></p></fn><fn id="nt112"><p><text><SENT sid="405" pm="."><plain>[23] and corrected for molybdenum content.4 Values from </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag><SecTag type="TABLE"><table-wrap id="pone-0082285-t004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0082285.t004</object-id><label>Table 4</label><caption><title><text><SENT sid="406" pm="."><plain>Reduction potentials of mAOX3 and selected variants determined by electron paramagnetic resonance spectroscopy and UV/Vis titrations. </plain></SENT>
</text></title></caption><alternatives><graphic id="pone-0082285-t004-4" xlink:href="pone.0082285.t004"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="407" pm="."><plain>Mo IV/V </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="408" pm="."><plain>Mo V/VI </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="409" pm="."><plain>FeSI </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="410" pm="."><plain>FeSII </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="411" pm="."><plain>FAD/FADH2 </plain></SENT>
</text></td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="412" pm="."><plain>mAOX3-WT </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="413" pm="."><plain>−468±11 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="414" pm="."><plain>−294±9 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="415" pm="."><plain>−206±10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="416" pm="."><plain>−286±12 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="417" pm="."><plain>−185±11 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="418" pm="."><plain>mAOX3-FeSI-mAOX1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="419" pm="."><plain>−44065 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="420" pm="."><plain>−234±33 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="421" pm="."><plain>−198±14 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="422" pm="."><plain>−230±21 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="423" pm="."><plain>−180±11 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="424" pm="."><plain>mAOX3-FeSII-mAOX1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="425" pm="."><plain>−441±38 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="426" pm="."><plain>−290±43 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="427" pm="."><plain>−273±22 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="428" pm="."><plain>−260±23 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="429" pm="."><plain>−201±11 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="430" pm="."><plain>mAOX3-FeSII-FeSI-mAOX1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="431" pm="."><plain>−422±28 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="432" pm="."><plain>−31329 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="433" pm="."><plain>−305±13 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="434" pm="."><plain>−261±22 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="435" pm="."><plain>−174±12 </plain></SENT>
</text></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt113"><p><text><SENT sid="436" pm="."><plain>Proteins were titrated anaerobically with sodium dithionite at room temperature in the presence of mediators as enlisted in experimental procedures. </plain></SENT>
<SENT sid="437" pm="."><plain>Signal intensities were determined by weighted fit of simulated spectra to experimental data. </plain></SENT>
<SENT sid="438" pm="."><plain>Weight parameters plotted against electrode potential were fitted to the Nernst-equation as described in experimental procedures. </plain></SENT>
<SENT sid="439" pm="."><plain>Reduction potentials of FeSI are lower in mAOX3 variants exhibiting iron sulfur domains from mAOX1. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag></sec><sec id="s2d"><title><text><SENT sid="440" pm="."><plain>Change of substrate specificity of mAOX3 </plain></SENT>
</text></title><p><text><SENT sid="441" pm="."><plain>The main amino acids involved in substrate binding in bXOR were shown to be E802 (A807 in mAOX3) and R880 (Y885 in mAOX3) [10], [30]. </plain></SENT>
<SENT sid="442" pm="."><plain>The highly conserved residues F914 (F919 in mAOX3) an F1009 in bXOR (F1014 in mAOX3) were shown to provide additional van-der-Waals interactions to the substrate [23], [31]. </plain></SENT>
<SENT sid="443" pm="."><plain>In AOX enzymes a conserved lysine (K889 in mAOX3) was proposed to be involved in substrate binding, which is a histidine in XORs. </plain></SENT>
<SENT sid="444" pm="."><plain>As reported previously, the mAOX3-K889H exchange decreased the catalytic activity 2–4 - fold, with lower KM values for most substrates, which suggested a better access of substrates to the active site due to the smaller side-chain [23]. </plain></SENT>
<SENT sid="445" pm="."><plain>We generated the variant mAOX3-“active site1” in which all residues in the first coordination sphere around the substrate except K889 were exchanged to their counterparts in XOR (F776K/A807E/D878L/L881S/Y885R/P1015T/Y1019L). </plain></SENT>
<SENT sid="446" pm="."><plain>The resulting variant mAOX3-“active site1” was devoid of activity towards most substrates tested. </plain></SENT>
<SENT sid="447" pm="."><plain>Only allopurinol was oxidized at a very low but significant rate of 14±1 min−1 (Table 5). </plain></SENT>
<SENT sid="448" pm="."><plain>However, additional introduction of the exchange of K889 to histidine in this variant recovered the activity with benzaldehyde, and phthalazine and, additionally, was able to convert hypoxanthine with a kcat of 25±1 min−1. </plain></SENT>
<SENT sid="449" pm="."><plain>Benzaldehyde and phthalazine were oxidized with higher rate constants in comparison to mAOX3 wild type, however, the KM values were largely increased. </plain></SENT>
<SENT sid="450" pm="."><plain>Thus, the additional introduction of K889H converted mAOX3 to a “XOR-type” enzyme (Figure 3). </plain></SENT>
<SENT sid="451" pm="."><plain>In order to test the additional effects of amino acids building a hydrogen-bond network in the second coordination sphere, we tested the “gating loop” variant (K889H/S1011G/V1012I/G1013S/K1016V/Y1020N) on substrate binding, in addition to variant mAOX3-“active site1 + gating loop”, which contains amino acid exchanges in the first and second coordination sphere (F776K/A807E/D878L/L881S/Y885R/K889H/S1011G/V1012I/G1013S/P1015T/K1016V/Y1019L/Y1020N). </plain></SENT>
<SENT sid="452" pm="."><plain>The affinity of mAOX3-“active site1 + gating loop” towards allopurinol, benzaldehyde and phthalazine was increased 3.7–22 fold in comparison to the variant mAOX3-“active site1”-K889H. </plain></SENT>
<SENT sid="453" pm="."><plain>On the other hand, the catalytic activity decreased 2–12 fold for these substrates. </plain></SENT>
<SENT sid="454" pm="."><plain>The catalytic efficiency of the mAOX3-“active site1 + gating loop” towards hypoxanthine was determined with values 5 times higher in comparison to mAOX3 wild type, but 2 times lower to that of the mAOX3-“active site1”-K889H variant. </plain></SENT>
<SENT sid="455" pm="."><plain>For comparison, a mAOX3 variant containing only the “gating loop” showed no detectable activity towards allopurinol, hypoxanthine and xanthine and only residual activity (1.3% in comparison to mAOX3 wild type) with benzaldehyde and phthalazine as substrates, showing that the additional amino acid exchanges are required to obtain a considerable activity. </plain></SENT>
<SENT sid="456" pm="."><plain>Thus, introduction of the “gating loop” exchange increased the substrate affinity in comparison to mAOX3-“active site1”-K889H, but resulted in a decrease in substrate conversion of the enzyme. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="pone-0082285-g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0082285.g003</object-id><label>Figure 3</label><caption><title><text><SENT sid="457" pm="."><plain>Active site structure of mAOX3. </plain></SENT>
</text></title><p><text><SENT sid="458" pm="."><plain>A, Stick representation of E1266 and residues exchanged in mAOX3-“active site1”-K889H in the crystal structure of mAOX3 WT (pdb:3ZYV). </plain></SENT>
<SENT sid="459" pm="."><plain>B, Stick representation of residues of desulfurated bXO (pdb:3EUB) corresponding to the amino acids in Panel A. </plain></SENT>
<SENT sid="460" pm="."><plain>C, Stick representation of residues in mAOX3 corresponding to the residues shown in Panel D. </plain></SENT>
<SENT sid="461" pm="."><plain>Y885 builds hydrogen-bonds to the backbone of G1013 and K889, indicated by yellow dotted lines D, Stick representation of residues involved in a hydrogen network at the entrance to the active site of bXOR. </plain></SENT>
<SENT sid="462" pm="."><plain>The hydrogen-bonding network is established by R880, G1006, I1007, S1008 and N1015 in bXOR represented by yellow dotted lines. </plain></SENT>
<SENT sid="463" pm="."><plain>Through the interactions, the position and orientation of T1010 is altered in comparison to K1016 of mAOX3 in panel C. </plain></SENT>
<SENT sid="464" pm="."><plain>Figures were created using MacPymol [56]Ver. </plain></SENT>
<SENT sid="465" pm="."><plain>0.99rc6. </plain></SENT>
</text></p></caption><graphic xlink:href="pone.0082285.g003"/></fig></SecTag><SecTag type="TABLE"><table-wrap id="pone-0082285-t005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0082285.t005</object-id><label>Table 5</label><caption><title><text><SENT sid="466" pm="."><plain>Steady-state kinetic parameters for mAOX3 wild type and mAOX3 variants containing numerous amino acids present in the active site of bovine XOR. </plain></SENT>
</text></title></caption><alternatives><graphic id="pone-0082285-t005-5" xlink:href="pone.0082285.t005"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="467" pm="."><plain>substrate </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="468" pm="."><plain>kinetic parameters1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="469" pm="."><plain>mAOX3-WT2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="470" pm="."><plain>mAOX3-“active site1” </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="471" pm="."><plain>mAOX3-“active site1”-K889H </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="472" pm="."><plain>mAOX3-“active site1 + gating loop” 4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="473" pm="."><plain>mAOX3-“gating loop” </plain></SENT>
</text></td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="474" pm="."><plain>benzaldehyde </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="475" pm="."><plain>kcat [min−1] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="476" pm="."><plain>68±15 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="477" pm="."><plain>n.d. </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="478" pm="."><plain>234±15 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="479" pm="."><plain>53±5 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="480" pm="."><plain>0.9±0.2 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="481" pm="."><plain>KM [µM] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="482" pm="."><plain>2.5±0.2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="483" pm="."><plain>n.d. </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="484" pm="."><plain>2122±88 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="485" pm="."><plain>571±36 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="486" pm="."><plain>4.5±3.4 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="487" pm="."><plain>kcat/KM [min−1 µM−1] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="488" pm="."><plain>27±6.4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="489" pm="."><plain>- </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="490" pm="."><plain>0.110±0.008 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="491" pm="."><plain>0.092±0.011 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="492" pm="."><plain>0.199±0.151 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="493" pm="."><plain>phthalazine </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="494" pm="."><plain>kcat [min−1] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="495" pm="."><plain>66±15 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="496" pm="."><plain>n.d. </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="497" pm="."><plain>524±33 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="498" pm="."><plain>42±7 (359±35)4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="499" pm="."><plain>0.9±0.1 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="500" pm="."><plain>KM [µM] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="501" pm="."><plain>1.4±0.2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="502" pm="."><plain>n.d. </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="503" pm="."><plain>733±52 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="504" pm="."><plain>33±18 (26806±2214)4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="505" pm="."><plain>0.9±0.5 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="506" pm="."><plain>kcat/KM [min−1 µM−1] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="507" pm="."><plain>47.3±12.7 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="508" pm="."><plain>- </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="509" pm="."><plain>0.715±0.068 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="510" pm="."><plain>1.287±0.744 (0.013±0.002)4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="511" pm="."><plain>0.997±0.559 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="512" pm="."><plain>hypoxanthine </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="513" pm="."><plain>kcat [min−1] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="514" pm="."><plain>2.1±0.4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="515" pm="."><plain>n.d. </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="516" pm="."><plain>25±1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="517" pm="."><plain>5±0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="518" pm="."><plain>n.d. </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="519" pm="."><plain>KM [µM] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="520" pm="."><plain>3685±854 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="521" pm="."><plain>n.d. </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="522" pm="."><plain>4085±227 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="523" pm="."><plain>1736±155 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="524" pm="."><plain>n.d. </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="525" pm="."><plain>kcat/KM [min−1 µM−1] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="526" pm="."><plain>0.00057±0.00018 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="527" pm="."><plain>- </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="528" pm="."><plain>0.00624±0.00048 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="529" pm="."><plain>0.00287±0.00035 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="530" pm="."><plain>- </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="531" pm="."><plain>allopurinol </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="532" pm="."><plain>kcat [min−1] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="533" pm="."><plain>73±16 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="534" pm="."><plain>14±1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="535" pm="."><plain>95±6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="536" pm="."><plain>39±3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="537" pm="."><plain>n.d. </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="538" pm="."><plain>KM [µM] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="539" pm="."><plain>1595±73 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="540" pm="."><plain>2933±380 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="541" pm="."><plain>133±10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="542" pm="."><plain>620±16 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="543" pm="."><plain>n.d. </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="544" pm="."><plain>kcat/KM [min−1 µM−1] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="545" pm="."><plain>0.0457±0.0103 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="546" pm="."><plain>0.005±0.001 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="547" pm="."><plain>0.718±0.067 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="548" pm="."><plain>0.063±0.005 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="549" pm="."><plain>- </plain></SENT>
</text></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt114"><p><text><SENT sid="550" pm="."><plain>µM DCPIP in 50 mM Tris (HCl) pH 8.00 at 37°C; kcat was corrected for molybdenum content1 Determined in the presence of 100 </plain></SENT>
</text></p></fn><fn id="nt115"><p><text><SENT sid="551" pm="."><plain>[23] and corrected for molybdenum content.2 Values from </plain></SENT>
</text></p></fn><fn id="nt116"><p><text><SENT sid="552" pm="."><plain>n.d. none detectable. </plain></SENT>
</text></p></fn><fn id="nt117"><p><text><SENT sid="553" pm="."><plain>4 phthalazine:DCPIP reaction was biphasic. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag></sec><sec id="s2e"><title><text><SENT sid="554" pm="."><plain>Molecular Docking </plain></SENT>
</text></title><p><text><SENT sid="555" pm="."><plain>To interpret the results of the kinetic analyzes, we performed molecular docking analyzes. </plain></SENT>
<SENT sid="556" pm="."><plain>We have first docked hypoxanthine and benzaldehyde into the active sites of the wild type and mAOX3 variants by using the molecular docking software AutoDock (Fig. 4 A and B). </plain></SENT>
<SENT sid="557" pm="."><plain>The most favorable complexes were then regarded as the initial geometries for the following MD simulations. </plain></SENT>
<SENT sid="558" pm="."><plain>The computational results showed that in the mAOX3 wild type, the position of the molybdenum coordination is partially stabilized by two important hydrogen bonds that are established with Q772 and E1266. </plain></SENT>
<SENT sid="559" pm="."><plain>Q772 established one hydrogen bond with the axial oxygen that is bound to the molybdenum ion (on average 2.50 Å) and E1266 interacts very closely with the hydroxyl group of the metal complex through a short hydrogen bond (on average 2.00 Å). </plain></SENT>
<SENT sid="560" pm="."><plain>S1085 and K889 stabilize the anionic nature of E1266. </plain></SENT>
<SENT sid="561" pm="."><plain>S1085 interacts with E1266 by a short hydrogen bond (on average 2.50 Å) while the K889 forms an ionic bridge with it (on average 3.50 Å). </plain></SENT>
</text></p><SecTag type="FIG"><fig id="pone-0082285-g004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0082285.g004</object-id><label>Figure 4</label><caption><title><text><SENT sid="562" pm="."><plain>Molecular docking and molecular dynamic studies. </plain></SENT>
</text></title><p><text><SENT sid="563" pm="."><plain>A, Wild type enzyme with hypoxanthine. </plain></SENT>
<SENT sid="564" pm="."><plain>B, Wild type enzyme with benzaldehyde bound in the active site. </plain></SENT>
<SENT sid="565" pm="."><plain>C, mAOX3-“active site1” variant with hypoxanthine. </plain></SENT>
<SENT sid="566" pm="."><plain>D, mAOX3-“active site1” variant with benzaldehyde bound in the active site. </plain></SENT>
<SENT sid="567" pm="."><plain>E, mAOX3-“active site1”-K889H with hypoxanthine. </plain></SENT>
<SENT sid="568" pm="."><plain>F, mAOX3-“active site1”-K889H with benzaldehyde bound in the active site. </plain></SENT>
<SENT sid="569" pm="."><plain>Hydrogen bonds are marked with a dashed line and the altered residues are highlighted in red. </plain></SENT>
</text></p></caption><graphic xlink:href="pone.0082285.g004"/></fig></SecTag><p><text><SENT sid="570" pm="."><plain>The computational results for the docking of hypoxanthine to mAOX3 wild type (Fig. 4A) showed a binding of the imidazole ring pointing towards the hydroxyl group of the molybdenum atom (2.04±0.20 Å). </plain></SENT>
<SENT sid="571" pm="."><plain>The position of hypoxanthine in the active site is stabilized by D878 trough a hydrogen bond involving the carbonyl group and by F919 via π-stacking interactions (∼3.35 Å). </plain></SENT>
<SENT sid="572" pm="."><plain>The modeled position of benzaldehyde in the active site is similar to the binding position of hypoxanthine (Fig. 4B). </plain></SENT>
<SENT sid="573" pm="."><plain>The aldehyde group resides close to the hydroxyl group of the Mo-OH group (3.46±0.18 Å) and is positioned correctly in order to be oxidized to the corresponding carboxylic acid. </plain></SENT>
<SENT sid="574" pm="."><plain>The conformation adopted by benzaldehyde is also guided by the π-stacking interactions with F919 (∼3.50 Å) and especially by K889, which establishes a hydrogen bond (3.13±0.60 Å). </plain></SENT>
</text></p><p><text><SENT sid="575" pm="."><plain>The computational results for the mAOX3-“active site1” variant showed that the metal cluster is deviated from the position that it occupies in the wild type enzyme. </plain></SENT>
<SENT sid="576" pm="."><plain>This occurs due to the disruption of key hydrogen bonds between the metal complex and E1266 or Q772. </plain></SENT>
<SENT sid="577" pm="."><plain>This fact is supported by a movement E1266 that no longer interacts with the hydroxyl group of the metal complex. </plain></SENT>
<SENT sid="578" pm="."><plain>The new conformation adopted by E1266 is endorsed by the ionic bridge provided by the Y885R variation (2.50 Å), but also by the close proximity of K889. </plain></SENT>
<SENT sid="579" pm="."><plain>We believe that the proximity of R885 and K889 in the active site creates a strong positively charged space that attracts the negatively charged E1266. </plain></SENT>
<SENT sid="580" pm="."><plain>All of these factors together might result in an inactive enzyme. </plain></SENT>
</text></p><p><text><SENT sid="581" pm="."><plain>The binding of hypoxanthine in the mAOX3-“active site1” variant is very different from the wild type enzyme (Figure 4C). </plain></SENT>
<SENT sid="582" pm="."><plain>The molecule has now flipped by 180° in the active site and the imidazole ring no longer interacts with the metal cluster. </plain></SENT>
<SENT sid="583" pm="."><plain>The D878L variation additionally precludes any interaction of the substrate with this part of the active site. </plain></SENT>
<SENT sid="584" pm="."><plain>In the wild type, the aspartate is responsible for making a hydrogen bond with the carbonyl group of hypoxanthine. </plain></SENT>
<SENT sid="585" pm="."><plain>The binding position of benzaldehyde in the mAOX3-“active site1” variant is also different from what is observed in the wild type enzyme (Figure 4D). </plain></SENT>
<SENT sid="586" pm="."><plain>However, in this case, the aldehyde group remained aligned with the hydroxyl group of the metal complex. </plain></SENT>
<SENT sid="587" pm="."><plain>The computational results suggest that the loss of activity might be related to the absence of the key interactions between the hydroxyl group and E1266. </plain></SENT>
</text></p><p><text><SENT sid="588" pm="."><plain>The additional introduction of the K889H exchange to the mAOX3-“active site1” variant resulted in an activity towards benzaldehyde and hypoxanthine. </plain></SENT>
<SENT sid="589" pm="."><plain>The studies showed that the overall rearrangement of the residues of the active site in the mAOX3-“active site1”-K889H variant closely resembled that of the wild type enzyme. </plain></SENT>
<SENT sid="590" pm="."><plain>The metal complex continues to be firmly aligned in the active site with the hydroxyl group pointing towards the entrance of the active site tunnel provided by E1266 and Q772. </plain></SENT>
<SENT sid="591" pm="."><plain>The main differences between the mAOX3-“active site1”-K889H variant and the wild type enzymes are at the top and bottom regions of the active site where the substrate binds. </plain></SENT>
<SENT sid="592" pm="."><plain>The variation of D878 to a leucine turns the top region of the active site almost hydrophobic, similarly to what is found in the mAOX3-“active site1” variant. </plain></SENT>
<SENT sid="593" pm="."><plain>Consequently, any interaction between the substrate and this region is precluded. </plain></SENT>
<SENT sid="594" pm="."><plain>At the bottom of the active site, the variations of Y885 to an arginine and K889 to a histidine, did not lead to any significant rearrangement of the active site, except to the closer ionic interaction between E1266 and R885. </plain></SENT>
<SENT sid="595" pm="."><plain>Interestingly, in this case the interaction between E1266 and the hydroxyl group of the metallic center is not destroyed. </plain></SENT>
<SENT sid="596" pm="."><plain>Here, K889H removes the high concentration of positive charge in a specific region of the active site. </plain></SENT>
<SENT sid="597" pm="."><plain>The binding poses of hypoxanthine in the variant and wild type enzymes are very similar (Fig. 4E). </plain></SENT>
<SENT sid="598" pm="."><plain>The imidazole ring remained close to the hydroxyl group of the metallic center (3.76±039 Å) but the molecule has flipped 180°. </plain></SENT>
<SENT sid="599" pm="."><plain>Thus, the carbonyl group no longer interacts with the top part of the active site, and establishes a hydrogen bond with R885 (1.98±0.22 Å). </plain></SENT>
<SENT sid="600" pm="."><plain>This shows that the important role of D878 in the wild type enzyme was replaced by R885 in the variant enzyme. </plain></SENT>
<SENT sid="601" pm="."><plain>Interestingly, in the wild type enzyme K889 occupies a similar position that is occupied by R885 in the mAOX3-“active site1”-K889H and bXOR. </plain></SENT>
<SENT sid="602" pm="."><plain>However in that case, the interaction between hypoxanthine and D878 is preferred instead. </plain></SENT>
<SENT sid="603" pm="."><plain>The binding poses of the benzaldehyde in the wild type and the mAOX3-“active site1”-K889H variant are also very similar (Fig. 4F). </plain></SENT>
<SENT sid="604" pm="."><plain>The aldehyde group is in close contact to the hydroxyl group of the metal complex. </plain></SENT>
<SENT sid="605" pm="."><plain>The changes in the orientations of the substrate are not observed here, since benzaldehyde does not interact with D878. </plain></SENT>
<SENT sid="606" pm="."><plain>However, in the mAOX3-“active site1”-K889H variant the presence of R885 allows the carbonyl group of the aldehyde to establish a hydrogen bond with this residue. </plain></SENT>
<SENT sid="607" pm="."><plain>Thus, this variation might improve the substrate recognition and turn the active site more prone for this type of substrates. </plain></SENT>
<SENT sid="608" pm="."><plain>This explains the improved activity of mAOX3-“active site1”-K889H with benzaldehyde. </plain></SENT>
</text></p></sec><sec id="s2f"><title><text><SENT sid="609" pm="."><plain>Conclusions </plain></SENT>
</text></title><p><text><SENT sid="610" pm="."><plain>AOX isoforms share a high amino acid sequence identity, however, their substrates specificities differ. </plain></SENT>
<SENT sid="611" pm="."><plain>Our results show that single variations of F1014 and P1015 in mAOX3 to residues found in mouse AOX homologues cannot explain the differences in the kinetic parameters to their full extent. </plain></SENT>
<SENT sid="612" pm="."><plain>Thus, more amino acid residues or synergistic effects determine the specificities and differences in the active site of these enzymes. </plain></SENT>
</text></p><p><text><SENT sid="613" pm="."><plain>This work also shows that exchange of iron-sulfur domains influence the rate constant but not the substrate affinity of mAOX3. </plain></SENT>
<SENT sid="614" pm="."><plain>This is in accordance with Moco-domain swop experiments performed with monkey and rat AOX orthologs [29]. </plain></SENT>
<SENT sid="615" pm="."><plain>A correlation of kcat and the difference in reduction potential between the Mo V/VI pair and FeSI was observed. </plain></SENT>
<SENT sid="616" pm="."><plain>However, our data do not allow favouring changes in the electron transfer or structural changes induced by the domain swop as a cause for the altered rate constants. </plain></SENT>
<SENT sid="617" pm="."><plain>Given the interaction at the interface of mAOX3 subdomains it seems impossible to alter the electron transfer without inducing structural changes. </plain></SENT>
</text></p><p><text><SENT sid="618" pm="."><plain>Additionally, XOR and AOX enzymes act on different, yet overlapping sets of substrates, and XOR enzymes usually show higher rate constants towards their specific substrates. </plain></SENT>
<SENT sid="619" pm="."><plain>Here, we present for the first time the successful conversion of an AOX enzyme to an XOR enzyme that can convert hypoxanthine as substrate. </plain></SENT>
<SENT sid="620" pm="."><plain>This change in substrate specificity was obtained by exchange of several amino acids in the substrate binding site. </plain></SENT>
<SENT sid="621" pm="."><plain>The results show the importance of K889 in retaining the interaction between E1266 and the hydroxyl group of the molybdenum atom (see Table 6 for a more detailed analysis). </plain></SENT>
<SENT sid="622" pm="."><plain>Thus, the inactivity of the AOX3-“active site1” variant is caused mainly by the disruption of a key hydrogen bond between E1266 and the hydroxyl group of the molybdenum site, a reaction essential to start the base-catalyzed mechanism. </plain></SENT>
<SENT sid="623" pm="."><plain>By additional introduction of the K889H exchange, the hydrogen bond network remained established. </plain></SENT>
<SENT sid="624" pm="."><plain>Thus, the results show that the conversion of the AOX to a XOR enzyme observed for the mAOX3-“active site1”-K889H variant is only possible because the interaction between E1266 and the hydroxyl group of the metal complex is not disrupted. </plain></SENT>
<SENT sid="625" pm="."><plain>In the case of hypoxanthine it is also important to emphasize that the absence of D878 is compensated by the mutation of Y885 by an arginine. </plain></SENT>
<SENT sid="626" pm="."><plain>This allows hypoxanthine to reside in a specific orientation in the active site with the imidazole ring pointing towards the metal complex ready for catalysis. </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="pone-0082285-t006" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0082285.t006</object-id><label>Table 6</label><caption><title><text><SENT sid="627" pm="."><plain>Interactions established by MD simulation within the metallic active center in the wild type and variant enzymes. </plain></SENT>
</text></title></caption><alternatives><graphic id="pone-0082285-t006-6" xlink:href="pone.0082285.t006"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="628" pm="."><plain>E1266-OH </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="629" pm="."><plain>E1266-S1085 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="630" pm="."><plain>Q772-O </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="631" pm="."><plain>D878-Sub </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="632" pm="."><plain>E1266-K889/R885* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="633" pm="."><plain>R885-Sub </plain></SENT>
</text></td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="634" pm="."><plain>mAOX3-WT </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="635" pm="."><plain>a) 1.87±0.16 b) 2.38±0.68 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="636" pm="."><plain>a) 1.79±0.15 a) 3.23±1.73 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="637" pm="."><plain>a) 2.33±0.28 b) 3.12±0.28 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="638" pm="."><plain>a) 5.05±0.48 b) Not available </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="639" pm="."><plain>a) 5.04±1.01 b) 3.29±0.73 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="640" pm="."><plain>Not available </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="641" pm="."><plain>mAOX3-“active site1” </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="642" pm="."><plain>a) 5.15±1.25 b) 5.82±0.42 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="643" pm="."><plain>a) 3.76±0.49 b) 1.97±0.32 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="644" pm="."><plain>a) 3.15±0.54 b) 2.22±0.50 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="645" pm="."><plain>a) Not available b) Not available </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="646" pm="."><plain>a) 3.18±0.50 b) 1.81±0.13 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="647" pm="."><plain>a) Not available a) Not available </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="648" pm="."><plain>mAOX3-“active site1”-K889H </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="649" pm="."><plain>a) 3.37±1.22 b) 2.17±0.79 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="650" pm="."><plain>a) 1.96±0.29 b) 2.00±0.30 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="651" pm="."><plain>a) 2.12±0.27 b) 2.61±0.42 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="652" pm="."><plain>a) Not available b) Not available </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="653" pm="."><plain>a) 2.17±0.43 b) 1.85±0.16 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="654" pm="."><plain>a) 1.98±0.22 a) 3.70±0.82 </plain></SENT>
</text></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt118"><p><text><SENT sid="655" pm="."><plain>*only available in the respective mutated enzymes. </plain></SENT>
</text></p></fn><fn id="nt119"><label/><p><text><SENT sid="656" pm="."><plain>a) substrate is hypoxanthine </plain></SENT>
</text></p></fn><fn id="nt120"><label/><p><text><SENT sid="657" pm="."><plain>b) substrate is benzaldehyde </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag></sec></sec></SecTag><SecTag type="METHODS"><sec sec-type="materials|methods" id="s3"><title><text><SENT sid="658" pm="."><plain>Materials and Methods </plain></SENT>
</text></title><sec id="s3a"><title><text><SENT sid="659" pm="."><plain>Protein Purification and site directed mutagenesis </plain></SENT>
</text></title><p><text><SENT sid="660" pm="."><plain>For site-directed mutagenesis of the presented mAOX3 variants, the expression vector pMMA1 [24] was used as a template. </plain></SENT>
<SENT sid="661" pm="."><plain>Base pair exchanges were introduced into pMMA1 by PCR mutagenesis. </plain></SENT>
<SENT sid="662" pm="."><plain>The mAOX3 gene containing base pair exchanges substituting F1014I, F1014V, P1015A and P1015G were cloned into the Pfl23II-SalI sites of pMMA1. </plain></SENT>
<SENT sid="663" pm="."><plain>Exchange of iron-sulfur domains was achieved by PCR-based fusion of the corresponding mAOX1 sequence derived from pSL205 [25] to the appropriate sequence from mAOX3 allowing cloning into the NdeI sites of pMMA1. </plain></SENT>
<SENT sid="664" pm="."><plain>Sequences coding for mAOX3-“active site1” variant (F776K/A807E/D878L/L881S/Y885R/P1015T/Y1019L) and the mAOX3-“gating loop” variant K889H/S1011G/V1012I/G1013S/K1016V/Y1020N) were cloned into the Pfl23II-SpeI sites of pMMA1. </plain></SENT>
<SENT sid="665" pm="."><plain>The variant mAOX3-“active site1”-K889H was created by PCR mutagenesis and cloned into the Pfl23II-SpeI sites of pMMA1. </plain></SENT>
<SENT sid="666" pm="."><plain>All constructs express the mAOX3 variants as N-terminal fusion proteins with a His6-tag. </plain></SENT>
<SENT sid="667" pm="."><plain>The mAOX3 wild type and variants were expressed and purified as reported previously [24]. </plain></SENT>
<SENT sid="668" pm="."><plain>The proteins were stored in 100 mM potassium phosphate pH 7.4 at −80°C until usage, without loss of activity. </plain></SENT>
<SENT sid="669" pm="."><plain>The molybdenum and iron contents were determined by ICP-OES as described previously [24]. </plain></SENT>
<SENT sid="670" pm="."><plain>The Moco content was quantified after conversion to its fluorescent oxidation product Form A as described in [32]. </plain></SENT>
</text></p></sec><sec id="s3b"><title><text><SENT sid="671" pm="."><plain>Enzyme Assays </plain></SENT>
</text></title><p><text><SENT sid="672" pm="."><plain>Steady state kinetics were performed at 37°C in 50 mM Tris-HCl (pH 8.0) and 1 mM EDTA with variable substrate concentrations (0–250 µM benzaldehyde for mAOX3 wild type, 0–5 mM benzaldehyde for mAOX3 variants, 0–5 mM N1-methylnicotineamide, 0– 400 µM phenanthridine, 0–8 mM hypoxanthine solved in 0.1 M NaOH for mAOX3 wild type, 0–5 mM hypoxanthine solved in 0.1 M NaOH for mAOX3 variants, 0–150 µM hypoxanthine solved in 0.1 M NaOH for bXOR and 0–5 mM allopurinol solved in 0.1 M NaOH) and protein concentrations in a range of 50–200 nM. </plain></SENT>
<SENT sid="673" pm="."><plain>As electron acceptor, 100 µM 2,6-dichlorophenolindophenol (DCPIP for mAOX3 variants) or molecular oxygen in air-saturated buffer (for phenanthridine) were used in a final reaction volume of 500 µl. </plain></SENT>
<SENT sid="674" pm="."><plain>Enzyme activity was monitored for 60 seconds at 600 nm for DCPIP and 321 nm for phenanthidine. </plain></SENT>
<SENT sid="675" pm="."><plain>Specific activity was calculated using the molecular extinction coefficient of 21,400 M−1cm−1 for mAOX3, 4775 M−1cm−1 for phenanthridine, and 16,100 M−1cm−1 for DCPIP [33]. </plain></SENT>
<SENT sid="676" pm="."><plain>Kinetic parameters were obtained by nonlinear fitting to the Michaelis-Menten model using R, build 2.12.00 [34]. </plain></SENT>
<SENT sid="677" pm="."><plain>Mean values with standard deviation were obtained from at least 3 independent measurements. kcat was normalized to a 100% molybdenum content. </plain></SENT>
</text></p></sec><sec id="s3c"><title><text><SENT sid="678" pm="."><plain>EPR-Redox Titration </plain></SENT>
</text></title><p><text><SENT sid="679" pm="."><plain>Anaerobic redox titrations were performed at ambient temperature (24±2°C) under constant mixing under 5% H2/95% N2 atmosphere (COYlab USA). </plain></SENT>
<SENT sid="680" pm="."><plain>The potentials were monitored with a platinum combination electrode with Ag/AgCl reference (Pt 5900 A, Schott Instruments, Germany) fitted to an inolab 7310 pH-meter (WTW Germany) calibrated with a saturated quinhydrone solution at pH 7 and 9. </plain></SENT>
<SENT sid="681" pm="."><plain>Reaction mixture contained 20 µM – 50 µM of protein, 5 µM of mediator and 100 mM potassium phosphate pH 7.4 in a total volume of 2 mL. </plain></SENT>
<SENT sid="682" pm="."><plain>The mediators used were 2,6-dichloroindophenol (217 mV), phenazinemethosulfate (80 mV), 1,4-naphtochinone (60 mV), toluideneblue (31 mV), methyleneblue (11 mV), indigocarmine (−125 mV), anthrachinone-2-sulfonate (−225 mV), phenosafranine (−252 mV), safranine T (−289 mV) and deiquat (−350 mV). </plain></SENT>
<SENT sid="683" pm="."><plain>The potential was titrated by stepwise addition of 5 µM–15 µM sodium dithionite (Na2S2O4) dissolved in 100 mM potassium phosphate pH 7.4. </plain></SENT>
<SENT sid="684" pm="."><plain>After stabilization of the potential (usually after 2 min), 80 µL of sample were withdrawn with a Hamilton syringe, transferred to a 4 mm EPR tube and frozen immediately in liquid nitrogen. </plain></SENT>
<SENT sid="685" pm="."><plain>9.5 GHz X-band cw-EPR spectroscopy was carried out on a home-assembled spectrometer consisting of an ER041 MR microwave bridge, a Stanford research lockin amplifier SR810, an AEG magnet with Bruker ER081S power supply and a Bruker SHQ resonator. </plain></SENT>
<SENT sid="686" pm="."><plain>EPR spectra were recorded at 10 K (for FeSII and FeSI) and 120 K (for Moco) using an Oxford ESR 910 helium flow cryostat controlled by an Oxford ITC502 temperature controller. </plain></SENT>
<SENT sid="687" pm="."><plain>The microwave frequency was measured with an Agilent 53181A frequency counter. </plain></SENT>
<SENT sid="688" pm="."><plain>For determination of g-values the magnetic field was calibrated with an external g-standard (LiLiF, g = 2.002293) [35]. </plain></SENT>
<SENT sid="689" pm="."><plain>Spectra were simulated using the EasySpin Toolbox (Build 4.5.0) and weights fitted to experimental data using Matlab's (R2012) trust-region-reflective non-negative least square algorithm. </plain></SENT>
<SENT sid="690" pm="."><plain>Weight parameters plotted against the potential were fitted with n = 1 to Nernst equation by non-linear regression using R build 2.12.0 [34]. </plain></SENT>
</text></p></sec><sec id="s3d"><title><text><SENT sid="691" pm="."><plain>UV-VIS-Redox Titrations </plain></SENT>
</text></title><p><text><SENT sid="692" pm="."><plain>Anaerobic redox titrations were performed at 22±1°C (Agilent 89090A #100 peltier) under 5% H2/95% N2 atmosphere (COYlab, USA). </plain></SENT>
<SENT sid="693" pm="."><plain>Mixing with 600 rpm was applied for 30 seconds after the addition of dithionite. </plain></SENT>
<SENT sid="694" pm="."><plain>The potentials were monitored with a platinum combination electrode with Ag/AgCl reference (Pt 5900 A, Schott Instruments, Germany) fitted to an Inolab 7310 pH-meter (WTW Germany) calibrated against saturated quinhydrone solution at pH 7 and 9. </plain></SENT>
<SENT sid="695" pm="."><plain>Reaction mixtures contained 3 µM–5 µM of protein in 100 mM potassium phosphate pH 7.4 in a total volume of 3 mL. </plain></SENT>
<SENT sid="696" pm="."><plain>The potential was titrated with stepwise addition of 1 µM–2 µM sodium dithionite (Na2S2O4) solved in 100 mM potassium phosphate pH 7.4. </plain></SENT>
<SENT sid="697" pm="."><plain>After stabilization of the potential (usually after 2 min), triplicate spectra were recorded on an Agilent 8453 and corrected for the absorbance in the range of 785–800 nm. </plain></SENT>
<SENT sid="698" pm="."><plain>Absorbance at 444 nm (for FAD) and 550 (for combined [2Fe-2S] centers) plotted against the potential was fitted with n = 2 to Nernst equation by non-linear regression using R build 2.12.0 [34]. </plain></SENT>
</text></p></sec><sec id="s3e"><title><text><SENT sid="699" pm="."><plain>Molecular Docking </plain></SENT>
</text></title><p><text><SENT sid="700" pm="."><plain>All the compounds were studied using the molecular docking software AutoDock [36] and the vsLab plug-in [37]. </plain></SENT>
<SENT sid="701" pm="."><plain>The structure of the receptor was built from the PDB structure of mouse AOX3 (pdb code 3ZYV at 2.9 Å of resolution). </plain></SENT>
<SENT sid="702" pm="."><plain>The ligands were built with GaussView [38] and they were protonated at physiological pH. </plain></SENT>
<SENT sid="703" pm="."><plain>In the docking process we used the Lamarckian genetic algorithm (LGA). </plain></SENT>
<SENT sid="704" pm="."><plain>The number of generations, energy evaluations, and docking runs were set to 370,000, 1,500,000, and 50, respectively. </plain></SENT>
<SENT sid="705" pm="."><plain>The types of atomic charges were taken as Kollman-all-atom for the receptor and Gasteiger for the compounds. </plain></SENT>
<SENT sid="706" pm="."><plain>The final solutions were retrieved from the molecular docking process according to the criteria of interacting energy. </plain></SENT>
</text></p></sec><sec id="s3f"><title><text><SENT sid="707" pm="."><plain>Molecular Modelling </plain></SENT>
</text></title><p><text><SENT sid="708" pm="."><plain>Since the crystallographic structure of mAOX3 has some gaps in its 3D sequence, the construction of these missing loops was carried out with program Modeller9 version 11 [39]–[42]. </plain></SENT>
<SENT sid="709" pm="."><plain>The missing parameters of the entire Moco cofactor (molybdenum penta-coordinated to molybdopterin, sulfido, oxo, and hydroxo ligands) were determined. </plain></SENT>
<SENT sid="710" pm="."><plain>The Moco model structure was optimized using DFT, with the exchange correlation functional B3LYP [43]–[45] and basis set 6-31G+(d) for all atoms except molybdenum, for which the LanL2DZ pseudopotential was employed. </plain></SENT>
<SENT sid="711" pm="."><plain>A semiflexible model approach was used to calculate the force constants for the bond and angles parameters of the molybdenum metallocenter [46]. </plain></SENT>
<SENT sid="712" pm="."><plain>Electrostatic charges were determined from a RESP fitting of Merz−Kollman charges [47]. </plain></SENT>
<SENT sid="713" pm="."><plain>Dihedral force constants involving the Mo were set to zero, while transferable van der Waals atomic parameters were taken from the literature [48]. </plain></SENT>
<SENT sid="714" pm="."><plain>The parameters for the Fe2S2 centers were taken from literature too [49]. </plain></SENT>
</text></p></sec><sec id="s3g"><title><text><SENT sid="715" pm="."><plain>Molecular Dynamics Simulation </plain></SENT>
</text></title><p><text><SENT sid="716" pm="."><plain>The structures of the six different complexes (wild type mAOX3:benzaldehyde, wild type mAOX3:hypoxanthine, mAOX3-“active-site1”:benzaldehyde, mAOX3-“active-site1”:hypoxanthine, mAOX3-“active-site1”-K889H:benzaldehyde and mAOX3-“active-site1-K889H”:hypoxanthine) were obtained from the previous docking protocol. </plain></SENT>
<SENT sid="717" pm="."><plain>For the parameterization of benzaldehyde and hypoxanthine the following protocol was used. </plain></SENT>
<SENT sid="718" pm="."><plain>The geometries of the molecules were built with GaussView software [38]. </plain></SENT>
<SENT sid="719" pm="."><plain>The optimized geometries and electronic properties were calculated with Gaussian09 software [50]. </plain></SENT>
<SENT sid="720" pm="."><plain>The restricted Hartree-Fock (RHF), with the 6-31G(d) basis set was used in all calculations. </plain></SENT>
<SENT sid="721" pm="."><plain>Atomic charges were recalculated using the RESP algorithm [47]. </plain></SENT>
<SENT sid="722" pm="."><plain>This methodology was chosen for its consistency with that adopted for the parameterization approach in AMBER 10.0 simulation package [51]. </plain></SENT>
<SENT sid="723" pm="."><plain>The geometry optimizations and a Molecular Dynamics (MD) simulation on the six complexes were performed with the parameterization adopted in AMBER 10.0, using the parm99SB force field for the protein and cofactors, and the generalized amber force field (GAFF) for the ligands [52]. </plain></SENT>
</text></p><p><text><SENT sid="724" pm="."><plain>All hydrogen atoms were added with the Amber software X-Leap [51], taking into account all residues in their physiological protonation state. </plain></SENT>
<SENT sid="725" pm="."><plain>The only exception was the D878, which was protonated. </plain></SENT>
<SENT sid="726" pm="."><plain>Twenty counter-ions (Na+) were employed to neutralize the high negative charges of the system. </plain></SENT>
<SENT sid="727" pm="."><plain>The X-Leap program was also used for this purpose. </plain></SENT>
<SENT sid="728" pm="."><plain>In these simulations, an explicit solvation model with pre-equilibrated TIP3P water molecules was used, filling a truncated octahedral box with a minimum distance of 12 Å between the box faces and any atom of each complex. </plain></SENT>
<SENT sid="729" pm="."><plain>The average size of each system was 172,000 atoms. </plain></SENT>
<SENT sid="730" pm="."><plain>The complex geometries were minimized in two stages: first the protein, cofactor and substrate were kept fixed and only the position of the water molecules was minimized. </plain></SENT>
<SENT sid="731" pm="."><plain>Afterwards the full system was minimized. </plain></SENT>
<SENT sid="732" pm="."><plain>Subsequently, an MD simulation of 100 ps at constant volume and temperature, and considering periodic boundaries conditions was run, followed by 2 ns of MD simulation with the NPT ensemble, in which Langevin dynamics was used (collision frequency of 1.0 ps−1) to control the temperature at 303.15 K [53]. </plain></SENT>
<SENT sid="733" pm="."><plain>These simulations were carried out using the Sander module. </plain></SENT>
<SENT sid="734" pm="."><plain>Bond lengths involving hydrogen atoms were constrained using the SHAKE algorithm, and the equations of motion were integrated with a 2 fs time step using the Verlet leapfrog algorithm [54]. </plain></SENT>
<SENT sid="735" pm="."><plain>The Particle-Mesh Ewald (PME) method [55] was used to include the long-range interactions, and the nonbonded interactions were truncated with a 10 Å cut-off. </plain></SENT>
<SENT sid="736" pm="."><plain>The MD trajectory was saved every 2 ps and the MD results were analysed with the PTRAJ module of AMBER 10.0 [51]. </plain></SENT>
</text></p></sec></sec></SecTag></body><back><SecTag type="REF"><ref-list><title>References</title><ref id="pone.0082285-Krenitsky1"><text><SENT sid="737" pm="."><plain>1 KrenitskyTA, NeilSM, ElionGB, HitchingsGH (1972) A comparison of the specificities of xanthine oxidase and aldehyde oxidase. Arch Biochem Biophys 150: 585–599.5044040 </plain></SENT>
</text></ref><ref id="pone.0082285-Kitamura1"><text><SENT sid="738" pm="."><plain>2 KitamuraS, SugiharaK, OhtaS (2006) Drug-metabolizing ability of molybdenum hydroxylases. Drug metabolism and pharmacokinetics 21: 83–98.16702728 </plain></SENT>
</text></ref><ref id="pone.0082285-Garattini1"><text><SENT sid="739" pm="."><plain>3 GarattiniE, MendelR, RomaoMJ, WrightR, TeraoM (2003) Mammalian molybdo-flavoenzymes, an expanding family of proteins: structure, genetics, regulation, function and pathophysiology. The Biochemical journal 372: 15–32.12578558 </plain></SENT>
</text></ref><ref id="pone.0082285-Johnson1"><text><SENT sid="740" pm="."><plain>4 JohnsonJL, ChaudhuryM, RajagopalanKV (1991) Identification of a molybdopterin-containing molybdenum cofactor in xanthine dehydrogenase from Pseudomonas aeruginosa. Biofactors 3: 103–107.1654922 </plain></SENT>
</text></ref><ref id="pone.0082285-Wahl1"><text><SENT sid="741" pm="."><plain>5 WahlRC, RajagopalanKV (1982) Evidence for the inorganic nature of the cyanolyzable sulfur of molybdenum hydroxylases. The Journal of biological chemistry 257: 1354–1359.6276383 </plain></SENT>
</text></ref><ref id="pone.0082285-Romao1"><text><SENT sid="742" pm="."><plain>6 RomaoMJ, ArcherM, MouraI, MouraJJ, LeGallJ, et al (1995) Crystal structure of the xanthine oxidase-related aldehyde oxido-reductase from D. gigas. Science 270: 1170–1176.7502041 </plain></SENT>
</text></ref><ref id="pone.0082285-Xia1"><text><SENT sid="743" pm="."><plain>7 XiaM, DempskiR, HilleR (1999) The reductive half-reaction of xanthine oxidase. </plain></SENT>
<SENT sid="744" pm="."><plain>Reaction with aldehyde substrates and identification of the catalytically labile oxygen. J Biol Chem 274: 3323–3330.9920873 </plain></SENT>
</text></ref><ref id="pone.0082285-Caldeira1"><text><SENT sid="745" pm="."><plain>8 CaldeiraJ, BelleV, AssoM, GuigliarelliB, MouraI, et al (2000) Analysis of the electron paramagnetic resonance properties of the [2Fe-2S]1+ centers in molybdenum enzymes of the xanthine oxidase family: assignment of signals I and II. Biochemistry 39: 2700–2707.10704221 </plain></SENT>
</text></ref><ref id="pone.0082285-Hille1"><text><SENT sid="746" pm="."><plain>9 HilleR (1996) The Mononuclear Molybdenum Enzymes. Chem Rev 96: 2757–2816.11848841 </plain></SENT>
</text></ref><ref id="pone.0082285-Enroth1"><text><SENT sid="747" pm="."><plain>10 EnrothC, EgerBT, OkamotoK, NishinoT, PaiEF (2000) Crystal structures of bovine milk xanthine dehydrogenase and xanthine oxidase: structure-based mechanism of conversion. Proceedings of the National Academy of Sciences of the United States of America 97: 10723–10728.11005854 </plain></SENT>
</text></ref><ref id="pone.0082285-Barber1"><text><SENT sid="748" pm="."><plain>11 BarberMJ, BrayRC, CammackR, CoughlanMP (1977) Oxidation—reduction potentials of turkey liver xanthine dehydrogenase and the origins of oxidase and dehydrogenase behaviour in molybdenum-containing hydroxylases. The Biochemical journal 163: 279–289.869927 </plain></SENT>
</text></ref><ref id="pone.0082285-Barber2"><text><SENT sid="749" pm="."><plain>12 BarberMJ, CoughlanMP, RajagopalanKV, SiegelLM (1982) Properties of the prosthetic groups of rabbit liver aldehyde oxidase: a comparison of molybdenum hydroxylase enzymes. Biochemistry 21: 3561–3568.6288079 </plain></SENT>
</text></ref><ref id="pone.0082285-Terao1"><text><SENT sid="750" pm="."><plain>13 TeraoM, KurosakiM, BarzagoMM, FratelliM, BagnatiR, et al (2009) Role of the molybdoflavoenzyme aldehyde oxidase homolog 2 in the biosynthesis of retinoic acid: generation and characterization of a knockout mouse. Mol Cell Biol 29: 357–377.18981221 </plain></SENT>
</text></ref><ref id="pone.0082285-Sigruener1"><text><SENT sid="751" pm="."><plain>14 SigruenerA, BuechlerC, OrsoE, HartmannA, WildPJ, et al (2007) Human aldehyde oxidase 1 interacts with ATP-binding cassette transporter-1 and modulates its activity in hepatocytes. Hormone and metabolic research  =  Hormon- und Stoffwechselforschung  =  Hormones et metabolisme 39: 781–789.17992631 </plain></SENT>
</text></ref><ref id="pone.0082285-Weigert1"><text><SENT sid="752" pm="."><plain>15 WeigertJ, NeumeierM, BauerS, MagesW, SchnitzbauerAA, et al (2008) Small-interference RNA-mediated knock-down of aldehyde oxidase 1 in 3T3-L1 cells impairs adipogenesis and adiponectin release. FEBS letters 582: 2965–2972.18671973 </plain></SENT>
</text></ref><ref id="pone.0082285-Merlin1"><text><SENT sid="753" pm="."><plain>16 MerlinC, FrancoisMC, BozzolanF, PelletierJ, Jacquin-JolyE, et al (2005) A new aldehyde oxidase selectively expressed in chemosensory organs of insects. Biochem Biophys Res Commun 332: 4–10.15896291 </plain></SENT>
</text></ref><ref id="pone.0082285-Garattini2"><text><SENT sid="754" pm="."><plain>17 GarattiniE, FratelliM, TeraoM (2009) The mammalian aldehyde oxidase gene family. Hum Genomics 4: 119–130.20038499 </plain></SENT>
</text></ref><ref id="pone.0082285-Garattini3"><text><SENT sid="755" pm="."><plain>18 GarattiniE, FratelliM, TeraoM (2008) Mammalian aldehyde oxidases: genetics, evolution and biochemistry. Cell Mol Life Sci 65: 1019–1048.18066686 </plain></SENT>
</text></ref><ref id="pone.0082285-Terao2"><text><SENT sid="756" pm="."><plain>19 TeraoM, KurosakiM, BarzagoMM, VarasanoE, BoldettiA, et al (2006) Avian and canine aldehyde oxidases. </plain></SENT>
<SENT sid="757" pm="."><plain>Novel insights into the biology and evolution of molybdo-flavoenzymes. The Journal of biological chemistry 281: 19748–19761.16672219 </plain></SENT>
</text></ref><ref id="pone.0082285-Vila1"><text><SENT sid="758" pm="."><plain>20 VilaR, KurosakiM, BarzagoMM, KolekM, BastoneA, et al (2004) Regulation and biochemistry of mouse molybdo-flavoenzymes. </plain></SENT>
<SENT sid="759" pm="."><plain>The DBA/2 mouse is selectively deficient in the expression of aldehyde oxidase homologues 1 and 2 and represents a unique source for the purification and characterization of aldehyde oxidase. The Journal of biological chemistry 279: 8668–8683.14665639 </plain></SENT>
</text></ref><ref id="pone.0082285-Kurosaki1"><text><SENT sid="760" pm="."><plain>21 KurosakiM, TeraoM, BarzagoMM, BastoneA, BernardinelloD, et al (2004) The aldehyde oxidase gene cluster in mice and rats. </plain></SENT>
<SENT sid="761" pm="."><plain>Aldehyde oxidase homologue 3, a novel member of the molybdo-flavoenzyme family with selective expression in the olfactory mucosa. The Journal of biological chemistry 279: 50482–50498.15383531 </plain></SENT>
</text></ref><ref id="pone.0082285-Obach1"><text><SENT sid="762" pm="."><plain>22 ObachRS (2004) Potent inhibition of human liver aldehyde oxidase by raloxifene. Drug Metab Dispos 32: 89–97.14709625 </plain></SENT>
</text></ref><ref id="pone.0082285-Coelho1"><text><SENT sid="763" pm="."><plain>23 CoelhoC, MahroM, TrincaoJ, CarvalhoAT, RamosMJ, et al (2012) The first mammalian aldehyde oxidase crystal structure: insights into substrate specificity. The Journal of biological chemistry 287: 40690–40702.23019336 </plain></SENT>
</text></ref><ref id="pone.0082285-Mahro1"><text><SENT sid="764" pm="."><plain>24 MahroM, CoelhoC, TrincaoJ, RodriguesD, TeraoM, et al (2011) Characterization and crystallization of mouse aldehyde oxidase 3: from mouse liver to Escherichia coli heterologous protein expression. Drug metabolism and disposition: the biological fate of chemicals 39: 1939–1945.21705476 </plain></SENT>
</text></ref><ref id="pone.0082285-Schumann1"><text><SENT sid="765" pm="."><plain>25 SchumannS, TeraoM, GarattiniE, SagguM, LendzianF, et al (2009) Site directed mutagenesis of amino acid residues at the active site of mouse aldehyde oxidase AOX1. PloS one 4: e5348.19401776 </plain></SENT>
</text></ref><ref id="pone.0082285-Hartmann1"><text><SENT sid="766" pm="."><plain>26 HartmannT, TeraoM, GarattiniE, TeutloffC, AlfaroJF, et al (2012) The impact of single nucleotide polymorphisms on human aldehyde oxidase. Drug metabolism and disposition: the biological fate of chemicals 40: 856–864.22279051 </plain></SENT>
</text></ref><ref id="pone.0082285-Yamaguchi1"><text><SENT sid="767" pm="."><plain>27 YamaguchiY, MatsumuraT, IchidaK, OkamotoK, NishinoT (2007) Human xanthine oxidase changes its substrate specificity to aldehyde oxidase type upon mutation of amino acid residues in the active site: roles of active site residues in binding and activation of purine substrate. J Biochem 141: 513–524.17301077 </plain></SENT>
</text></ref><ref id="pone.0082285-Coughlan1"><text><SENT sid="768" pm="."><plain>28Coughlan MP (1980) Aldehyde oxidase, xanthine oxidase and xanthine dehydrogenase; hydroxylases containing molybdenum, iron-sulphur and flavin. </plain></SENT>
<SENT sid="769" pm="."><plain>In: M. </plain></SENT>
<SENT sid="770" pm="."><plain>P Coughlan, editor editors. </plain></SENT>
<SENT sid="771" pm="."><plain>Molybdenum and Molybdenum-Containing Enzymes. </plain></SENT>
<SENT sid="772" pm="."><plain>Oxford: Pergamon Press. pp. </plain></SENT>
<SENT sid="773" pm="."><plain>119–185. </plain></SENT>
</text></ref><ref id="pone.0082285-Itoh1"><text><SENT sid="774" pm="."><plain>29 ItohK, AsakawaT, HoshinoK, AdachiM, FukiyaK, et al (2009) Functional analysis of aldehyde oxidase using expressed chimeric enzyme between monkey and rat. Biological &amp; pharmaceutical bulletin 32: 31–35.19122276 </plain></SENT>
</text></ref><ref id="pone.0082285-Leimkhler1"><text><SENT sid="775" pm="."><plain>30 LeimkühlerS, StockertAL, IgarashiK, NishinoT, HilleR (2004) The role of active site glutamate residues in catalysis of Rhodobacter capsulatus xanthine dehydrogenase. The Journal of biological chemistry 279: 40437–40444.15265866 </plain></SENT>
</text></ref><ref id="pone.0082285-Okamoto1"><text><SENT sid="776" pm="."><plain>31Okamoto K, Kawaguchi Y, Eger BT, Pai EF, Nishino T (2010) Crystal Structures of Urate Bound Form of Xanthine Oxidoreductase: Substrate Orientation and Structure of the Key Reaction Intermediate. </plain></SENT>
<SENT sid="777" pm="."><plain>Journal of the American Chemical Society. </plain></SENT>
</text></ref><ref id="pone.0082285-Neumann1"><text><SENT sid="778" pm="."><plain>32 NeumannM, MittelstädtG, SedukF, Iobbi-NivolC, LeimkühlerS (2009) MocA is a specific cytidylyltransferase involved in molybdopterin cytosine dinucleotide biosynthesis in Escherichia coli . The Journal of biological chemistry 284: 21891–21898.19542235 </plain></SENT>
</text></ref><ref id="pone.0082285-Koiwai1"><text><SENT sid="779" pm="."><plain>33 KoiwaiH, AkabaS, SeoM, KomanoT, KoshibaT (2000) Functional expression of two Arabidopsis aldehyde oxidases in the yeast Pichia pastoris. . Journal of biochemistry 127: 659–664.10739959 </plain></SENT>
</text></ref><ref id="pone.0082285-Team1"><text><SENT sid="780" pm="."><plain>34Team RDC (2010) R: A Language and Environment for Statistical Computing. </plain></SENT>
</text></ref><ref id="pone.0082285-Stesmans1"><text><SENT sid="781" pm="."><plain>35 StesmansA, VangorpG (1989) Novel Method for Accurate G-Measurements in Electron-Spin Resonance. Rev Sci Instrum 60: 2949–2952. </plain></SENT>
</text></ref><ref id="pone.0082285-Morris1"><text><SENT sid="782" pm="."><plain>36 MorrisGM, GoodsellDS, HueyR, OlsonAJ (1996) Distributed automated docking of flexible ligands to proteins: parallel applications of AutoDock 2.4. J Comput Aided Mol Des 10: 293–304.8877701 </plain></SENT>
</text></ref><ref id="pone.0082285-Cerqueira1"><text><SENT sid="783" pm="."><plain>37 CerqueiraN, RibeiroJ, FernandesPA, RamosMJ (2011) vsLab-An Implementation for Virtual High-Throughput Screening Using AutoDock and VMD. International Journal of Quantum Chemistry 111: 1208–1212. </plain></SENT>
</text></ref><ref id="pone.0082285-Gaussian1"><text><SENT sid="784" pm="."><plain>38Gaussian Inc. </plain></SENT>
<SENT sid="785" pm="."><plain>COP, Bldg. </plain></SENT>
<SENT sid="786" pm="."><plain>6, Pittsburgh, PA 15106, USA. </plain></SENT>
</text></ref><ref id="pone.0082285-Sali1"><text><SENT sid="787" pm="."><plain>39 SaliA, BlundellTL (1993) COMPARATIVE PROTEIN MODELING BY SATISFACTION OF SPATIAL RESTRAINTS. Journal of Molecular Biology 234: 779–815.8254673 </plain></SENT>
</text></ref><ref id="pone.0082285-Fiser1"><text><SENT sid="788" pm="."><plain>40 FiserA, DoRKG, SaliA (2000) Modeling of loops in protein structures. Protein Science 9: 1753–1773.11045621 </plain></SENT>
</text></ref><ref id="pone.0082285-MartiRenom1"><text><SENT sid="789" pm="."><plain>41 Marti-RenomMA, StuartAC, FiserA, SanchezR, MeloF, et al (2000) Comparative protein structure modeling of genes and genomes. Annual Review of Biophysics and Biomolecular Structure 29: 291–325. </plain></SENT>
</text></ref><ref id="pone.0082285-Eswar1"><text><SENT sid="790" pm="."><plain>42Eswar N, Marti-Renom MA, Webb B, Madhusudhan MS, Eramian D, et al.. </plain></SENT>
<SENT sid="791" pm="."><plain>(2006) Comparative Protein Structure Modeling With MODELLER. </plain></SENT>
<SENT sid="792" pm="."><plain>Current Protocols in Bioinformatics. </plain></SENT>
<SENT sid="793" pm="."><plain>In: I. </plain></SENT>
<SENT sid="794" pm="."><plain>John Wiley &amp; Sons, editor editors. </plain></SENT>
<SENT sid="795" pm="."><plain>Current Protocols in Bioinformatics. </plain></SENT>
</text></ref><ref id="pone.0082285-Becke1"><text><SENT sid="796" pm="."><plain>43 BeckeAD (1996) Density-functional thermochemistry.4. </plain></SENT>
<SENT sid="797" pm="."><plain>A new dynamical correlation functional and implications for exact-exchange mixing. J Chem Phys 104: 1040–1046. </plain></SENT>
</text></ref><ref id="pone.0082285-Becke2"><text><SENT sid="798" pm="."><plain>44 BeckeAD (1988) Density-Functional Exchange-Energy Approximation with Correct Asymptotic-Behavior. Physical Review A 38: 3098–3100. </plain></SENT>
</text></ref><ref id="pone.0082285-Lee1"><text><SENT sid="799" pm="."><plain>45 LeeCT, YangWT, ParrRG (1988) Development of the Colle-Salvetti Correlation-Energy Formula into a Functional of the Electron-Density. Physical Review B 37: 785–789. </plain></SENT>
</text></ref><ref id="pone.0082285-Neves1"><text><SENT sid="800" pm="."><plain>46 NevesRPP, SousaSF, FernandesPA, RamosMJ (2013) Parameters for Molecular Dynamics Simulations of Manganese-Containing Metalloproteins. Journal of Chemical Theory and Computation 9: 2718–2732.26583865 </plain></SENT>
</text></ref><ref id="pone.0082285-Bayly1"><text><SENT sid="801" pm="."><plain>47 BaylyCI, CieplakP, CornellWD, KollmanPA (1993) A Well-Behaved Electrostatic Potential Based Method Using Charge Restraints for Deriving Atomic Charges - the Resp Model. Journal of Physical Chemistry 97: 10269–10280. </plain></SENT>
</text></ref><ref id="pone.0082285-Batsanov1"><text><SENT sid="802" pm="."><plain>48 BatsanovSS (2001) Van der Waals radii of elements. Inorganic Materials 37: 871–885. </plain></SENT>
</text></ref><ref id="pone.0082285-Carvalho1"><text><SENT sid="803" pm="."><plain>49 CarvalhoATP, TeixeiraAFS, RamosMJ (2013) Parameters for molecular dynamics simulations of iron-sulfur proteins. Journal of Computational Chemistry 34: 1540–1548.23609049 </plain></SENT>
</text></ref><ref id="pone.0082285-Frisch1"><text><SENT sid="804" pm="."><plain>50Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE; Robb, et al.. </plain></SENT>
<SENT sid="805" pm="."><plain>(2009) Gaussian 09. </plain></SENT>
<SENT sid="806" pm="."><plain>Wallingford CT: Gaussian, Inc. </plain></SENT>
</text></ref><ref id="pone.0082285-Case1"><text><SENT sid="807" pm="."><plain>51Case DA, Darden TA, Cheatham III TE, Simmerling CL, Wang J, Duke RE, et al.. </plain></SENT>
<SENT sid="808" pm="."><plain>(2008) AMBER 10, University of California, San Francisco. </plain></SENT>
</text></ref><ref id="pone.0082285-Wang1"><text><SENT sid="809" pm="."><plain>52 WangJM, WolfRM, CaldwellJW, KollmanPA, CaseDA (2004) Development and testing of a general amber force field. Journal of Computational Chemistry 25: 1157–1174.15116359 </plain></SENT>
</text></ref><ref id="pone.0082285-Izaguirre1"><text><SENT sid="810" pm="."><plain>53 IzaguirreJA, CatarelloDP, WozniakJM, SkeelRD (2001) Langevin stabilization of molecular dynamics. J Chem Phys 114: 2090–2098. </plain></SENT>
</text></ref><ref id="pone.0082285-Ryckaert1"><text><SENT sid="811" pm="."><plain>54 RyckaertJP, CiccottiG, BerendsenHJC (1977) Numerical-Integration of Cartesian Equations of Motion of a System with Constraints - Molecular-Dynamics of N-Alkanes. J Comput Phys 23: 327–341. </plain></SENT>
</text></ref><ref id="pone.0082285-Essmann1"><text><SENT sid="812" pm="."><plain>55 EssmannU, PereraL, BerkowitzML, DardenT, LeeH, et al (1995) A SMOOTH PARTICLE MESH EWALD METHOD. J Chem Phys 103: 8577–8593. </plain></SENT>
</text></ref><ref id="pone.0082285-Schrodinger1"><text><SENT sid="813" pm="."><plain>56Schrodinger LLC (2010) The PyMOL Molecular Graphics System, Version 1.3r1. </plain></SENT>
</text></ref></ref-list></SecTag></back></article>
